These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
|
||
|
SECURITIES AND EXCHANGE COMMISSION
|
||
|
|
Washington, D.C. 20549
|
|
|
FORM 10-K
|
||
|
(Mark One)
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended January 28, 2017
|
|
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from to
|
|
|
Commission file number
1-6049
|
|
|
Minnesota
(State or other jurisdiction of
incorporation or organization)
|
|
41-0215170
(I.R.S. Employer
Identification No.)
|
|
1000 Nicollet Mall, Minneapolis, Minnesota
(Address of principal executive offices)
|
|
55403
(Zip Code)
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock, par value $0.0833 per share
|
|
New York Stock Exchange
|
|
Securities registered pursuant to Section 12(g) of the Act:
None
|
||
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
DOCUMENTS INCORPORATED BY REFERENCE
|
|
Portions of Target's Proxy Statement to be filed on or about May 1, 2017 are incorporated into Part III.
|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
Owned Brands
|
|
|
|
Archer Farms®
|
Market Pantry®
|
Sutton & Dodge®
|
|
Art Class™
|
Merona®
|
Threshold™
|
|
Ava & Viv®
|
Pillowfort™
|
up & up®
|
|
Boots & Barkley®
|
Room Essentials®
|
Wine Cube®
|
|
Cat & Jack™
|
Simply Balanced™
|
Wondershop™
|
|
Embark®
|
Smith & Hawken®
|
Xhilaration®
|
|
Gilligan & O'Malley®
|
Sonia Kashuk®
|
|
|
Knox Rose™
|
Spritz™
|
|
|
|
|
|
|
Exclusive Brands
|
|
|
|
C9 by Champion®
|
Hand Made Modern®
|
Mossimo®
|
|
DENIZEN® from Levi's®
|
Just One You® made by carter's®
|
Nate Berkus for Target
|
|
Fieldcrest®
|
Kid Made Modern®
|
Oh Joy!® for Target
|
|
Genuine Kids® from OshKosh®
|
Liz Lange® for Target
|
|
|
Stores at
January 28, 2017
|
Stores
|
|
Retail Sq. Ft.
(in thousands)
|
|
|
|
Stores
|
|
Retail Sq. Ft.
(in thousands)
|
|
|
Alabama
|
22
|
|
3,150
|
|
|
Montana
|
7
|
|
780
|
|
|
Alaska
|
3
|
|
504
|
|
|
Nebraska
|
14
|
|
2,006
|
|
|
Arizona
|
46
|
|
6,136
|
|
|
Nevada
|
17
|
|
2,230
|
|
|
Arkansas
|
9
|
|
1,165
|
|
|
New Hampshire
|
9
|
|
1,148
|
|
|
California
|
273
|
|
35,575
|
|
|
New Jersey
|
46
|
|
5,929
|
|
|
Colorado
|
41
|
|
6,215
|
|
|
New Mexico
|
10
|
|
1,185
|
|
|
Connecticut
|
20
|
|
2,672
|
|
|
New York
|
75
|
|
9,961
|
|
|
Delaware
|
3
|
|
440
|
|
|
North Carolina
|
49
|
|
6,496
|
|
|
District of Columbia
|
1
|
|
179
|
|
|
North Dakota
|
4
|
|
554
|
|
|
Florida
|
122
|
|
17,135
|
|
|
Ohio
|
61
|
|
7,659
|
|
|
Georgia
|
51
|
|
6,916
|
|
|
Oklahoma
|
15
|
|
2,168
|
|
|
Hawaii
|
6
|
|
971
|
|
|
Oregon
|
19
|
|
2,280
|
|
|
Idaho
|
6
|
|
664
|
|
|
Pennsylvania
|
69
|
|
8,741
|
|
|
Illinois
|
92
|
|
12,361
|
|
|
Rhode Island
|
4
|
|
517
|
|
|
Indiana
|
31
|
|
4,174
|
|
|
South Carolina
|
19
|
|
2,359
|
|
|
Iowa
|
20
|
|
2,835
|
|
|
South Dakota
|
5
|
|
580
|
|
|
Kansas
|
18
|
|
2,473
|
|
|
Tennessee
|
31
|
|
3,990
|
|
|
Kentucky
|
13
|
|
1,551
|
|
|
Texas
|
147
|
|
20,726
|
|
|
Louisiana
|
16
|
|
2,246
|
|
|
Utah
|
13
|
|
1,953
|
|
|
Maine
|
5
|
|
630
|
|
|
Vermont
|
—
|
|
—
|
|
|
Maryland
|
39
|
|
4,952
|
|
|
Virginia
|
58
|
|
7,689
|
|
|
Massachusetts
|
40
|
|
5,188
|
|
|
Washington
|
37
|
|
4,328
|
|
|
Michigan
|
55
|
|
6,603
|
|
|
West Virginia
|
6
|
|
755
|
|
|
Minnesota
|
75
|
|
10,634
|
|
|
Wisconsin
|
37
|
|
4,560
|
|
|
Mississippi
|
6
|
|
743
|
|
|
Wyoming
|
2
|
|
187
|
|
|
Missouri
|
35
|
|
4,609
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
1,802
|
|
239,502
|
|
|
Stores and Distribution Centers at January 28, 2017
|
Stores
|
|
Distribution
Centers
(a)
|
|
|
Owned
|
1,535
|
|
33
|
|
|
Leased
|
107
|
|
7
|
|
|
Owned buildings on leased land
|
160
|
|
—
|
|
|
Total
|
1,802
|
|
40
|
|
|
Name
|
Title and Business Experience
|
Age
|
|
|
|
|
|
|
|
Casey L. Carl
|
Executive Vice President and Chief Strategy and Innovation Officer since December 2014. President, Omnichannel and Senior Vice President, Enterprise Strategy from July 2014 to December 2014. President, Multichannel, from November 2011 to July 2014.
|
41
|
|
|
Brian C. Cornell
|
Chairman of the Board and Chief Executive Officer since August 2014. Chief Executive Officer of PepsiCo Americas Foods, a division of PepsiCo, Inc., a multinational food and beverage corporation, from March 2012 to July 2014.
|
58
|
|
|
Rick H. Gomez
|
Executive Vice President and Chief Marketing Officer since January 2017. Senior Vice President, Brand and Category Marketing from April 2013 to January 2017. Vice President, Brand Marketing at MillerCoors, a multinational brewing company, from April 2011 to April 2013.
|
47
|
|
|
Don H. Liu
|
Executive Vice President, Chief Legal Officer and Corporate Secretary since August 2016. Executive Vice President, General Counsel and Corporate Secretary of Xerox Corporation from July 2014 to July 2016, and Senior Vice President, General Counsel and Corporate Secretary from March 2007 to August 2014.
|
55
|
|
|
Stephanie A. Lundquist
|
Executive Vice President and Chief Human Resources Officer since February 2016. Senior Vice President, Human Resources from January 2015 to February 2016. Senior Vice President, Stores and Distribution Human Resources from February 2014 to January 2015. From March 2011 to January 2014, Ms. Lundquist held several leadership positions with Target Canada.
|
41
|
|
|
Michael E. McNamara
|
Executive Vice President, Chief Information and Digital Officer since September 2016. Executive Vice President and Chief Information Officer from June 2015 to September 2016. Chief Information Officer of Tesco PLC, a multinational grocery and general merchandise retailer, from March 2011 to May 2015.
|
52
|
|
|
John J. Mulligan
|
Executive Vice President and Chief Operating Officer since September 2015. Executive Vice President and Chief Financial Officer from April 2012 to August 2015.
|
51
|
|
|
Janna A. Potts
|
Executive Vice President and Chief Stores Officer since January 2016. Senior Vice President, Stores and Supply Chain Human Resources from February 2015 to January 2016. Senior Vice President, Target Canada Stores and Distribution from March 2014 to January 2015. Senior Vice President, Store Operations from August 2009 to March 2014.
|
49
|
|
|
Jacqueline Hourigan Rice
|
Executive Vice President and Chief Risk and Compliance Officer since December 2014. Chief Compliance Officer of General Motors Company, a vehicle manufacturer, from March 2013 to November 2014. Executive Director, Global Ethics & Compliance of General Motors Company from January 2010 to February 2013.
|
45
|
|
|
Cathy R. Smith
|
Executive Vice President and Chief Financial Officer since September 2015. Executive Vice President and Chief Financial Officer of Express Scripts Holding Company, a pharmacy benefit manager, from February 2014 to December 2014. Executive Vice President of Strategy and Chief Financial Officer for Walmart International, a division of Wal-Mart Stores, Inc., a discount retailer, from March 2010 to January 2014.
|
53
|
|
|
Mark J. Tritton
|
Executive Vice President and Chief Merchandising Officer since June 2016. President of Nordstrom Product Group, of Nordstrom Inc., a fashion specialty retailer, from June 2009 to June 2016.
|
53
|
|
|
Laysha L. Ward
|
Executive Vice President and Chief External Engagement Officer since January 2017.
Chief Corporate Social Responsibility Officer from December 2014 to January 2017. President, Community Relations and Target Foundation from July 2008 to December 2014.
|
49
|
|
|
Period
|
Total Number
of Shares
Purchased
|
|
|
Average
Price
Paid per
Share
|
|
|
Total Number of
Shares Purchased
as Part of Publicly Announced Programs
|
|
|
Dollar Value of
Shares that May
Yet Be Purchased
Under Publicly
Announced Programs
|
|
||
|
October 30, 2016 through November 26, 2016
|
|
|
|
|
|
|
|
||||||
|
Open market and privately negotiated purchases
|
802,412
|
|
|
$
|
67.23
|
|
|
802,412
|
|
|
$
|
5,210,467,654
|
|
|
September 2016 ASR
(a)
|
1,286,423
|
|
|
67.67
|
|
|
1,286,423
|
|
|
5,246,730,198
|
|
||
|
November 27, 2016 through December 31, 2016
|
|
|
|
|
|
|
|
||||||
|
Open market and privately negotiated purchases
|
—
|
|
|
—
|
|
|
—
|
|
|
5,246,730,198
|
|
||
|
December 2016 ASR
|
4,618,451
|
|
|
76.77
|
|
|
4,618,451
|
|
|
4,892,156,933
|
|
||
|
January 1, 2017 through January 28, 2017
|
|
|
|
|
|
|
|
||||||
|
Open market and privately negotiated purchases
|
2,362,745
|
|
|
66.27
|
|
|
2,362,745
|
|
|
4,735,572,452
|
|
||
|
Total
|
9,070,031
|
|
|
$
|
71.90
|
|
|
9,070,031
|
|
|
$
|
4,735,572,452
|
|
|
(a)
|
Represents the incremental shares received upon final settlement of the accelerated share repurchase agreement (ASR) initiated in third quarter 2016.
|
|
|
Fiscal Years Ended
|
|||||||||||||||||
|
|
January 28,
2012 |
|
February 2,
2013 |
|
February 1,
2014 |
|
January 31,
2015 |
|
January 30,
2016 |
|
January 28,
2017 |
|
||||||
|
Target
|
$
|
100.00
|
|
$
|
124.97
|
|
$
|
118.53
|
|
$
|
158.98
|
|
$
|
160.89
|
|
$
|
146.06
|
|
|
S&P 500 Index
|
100.00
|
|
117.61
|
|
141.49
|
|
161.61
|
|
160.54
|
|
194.04
|
|
||||||
|
Peer Group
|
100.00
|
|
127.43
|
|
154.12
|
|
191.03
|
|
208.03
|
|
231.50
|
|
||||||
|
|
As of or for the Fiscal Year Ended
|
||||||||||||||
|
(millions, except per share data)
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
(a)
|
|
|||||
|
Sales
(b)
|
$
|
69,495
|
|
$
|
73,785
|
|
$
|
72,618
|
|
$
|
71,279
|
|
$
|
73,301
|
|
|
Net Earnings
/
(Loss)
|
|
|
|
|
|
||||||||||
|
Continuing operations
|
2,669
|
|
3,321
|
|
2,449
|
|
2,694
|
|
3,315
|
|
|||||
|
Discontinued operations
|
68
|
|
42
|
|
(4,085
|
)
|
(723
|
)
|
(316
|
)
|
|||||
|
Net earnings /
(loss)
|
2,737
|
|
3,363
|
|
(1,636
|
)
|
1,971
|
|
2,999
|
|
|||||
|
Basic Earnings
/
(Loss) Per Share
|
|
|
|
|
|
||||||||||
|
Continuing operations
|
4.62
|
|
5.29
|
|
3.86
|
|
4.24
|
|
5.05
|
|
|||||
|
Discontinued operations
|
0.12
|
|
0.07
|
|
(6.44
|
)
|
(1.14
|
)
|
(0.48
|
)
|
|||||
|
Basic earnings /
(loss) per share
|
4.74
|
|
5.35
|
|
(2.58
|
)
|
3.10
|
|
4.57
|
|
|||||
|
Diluted Earnings
/
(Loss) Per Share
|
|
|
|
|
|
||||||||||
|
Continuing operations
|
4.58
|
|
5.25
|
|
3.83
|
|
4.20
|
|
5.00
|
|
|||||
|
Discontinued operations
|
0.12
|
|
0.07
|
|
(6.38
|
)
|
(1.13
|
)
|
(0.48
|
)
|
|||||
|
Diluted earnings /
(loss) per share
|
4.70
|
|
5.31
|
|
(2.56
|
)
|
3.07
|
|
4.52
|
|
|||||
|
Cash dividends declared per share
|
2.36
|
|
2.20
|
|
1.99
|
|
1.65
|
|
1.38
|
|
|||||
|
|
|
|
|
|
|
||||||||||
|
Total assets
|
37,431
|
|
40,262
|
|
41,172
|
|
44,325
|
|
47,878
|
|
|||||
|
Long-term debt, including current portion
|
12,749
|
|
12,760
|
|
12,725
|
|
12,494
|
|
16,260
|
|
|||||
|
(a)
|
Consisted of 53 weeks.
|
|
(b)
|
For 2012, includes credit card revenues.
|
|
•
|
GAAP earnings per share from continuing operations were
$4.58
.
|
|
•
|
Adjusted earnings per share were
$5.01
.
|
|
•
|
Comparable sales decreased
0.5 percent
, reflecting a
0.8 percent
decrease in traffic.
|
|
•
|
Comparable digital channel sales growth of 27 percent contributed 1.0 percentage points of comparable sales growth.
|
|
•
|
We returned $5.0 billion to shareholders through dividends and share repurchase.
|
|
Earnings Per Share From
Continuing Operations
|
|
|
|
Percent Change
|
|||||||||
|
2016
|
|
2015
|
|
2014
|
|
2016/2015
|
|
2015/2014
|
|
||||
|
GAAP diluted earnings per share
|
$
|
4.58
|
|
$
|
5.25
|
|
$
|
3.83
|
|
(12.7
|
)%
|
37.2
|
%
|
|
Adjustments
|
0.42
|
|
(0.56
|
)
|
0.39
|
|
|
|
|
|
|||
|
Adjusted diluted earnings per share
|
$
|
5.01
|
|
$
|
4.69
|
|
$
|
4.22
|
|
6.7
|
%
|
11.3
|
%
|
|
|
|
|
|
Percent Change
|
|||||||||
|
(dollars in millions)
|
2016
|
|
2015
(a)
|
|
2014
(a)
|
|
2016/2015
|
|
2015/2014
|
|
|||
|
Sales
|
$
|
69,495
|
|
$
|
73,785
|
|
$
|
72,618
|
|
(5.8
|
)%
|
1.6
|
%
|
|
Cost of sales
|
48,872
|
|
51,997
|
|
51,278
|
|
(6.0
|
)
|
1.4
|
|
|||
|
Gross margin
|
20,623
|
|
21,788
|
|
21,340
|
|
(5.4
|
)
|
2.1
|
|
|||
|
SG&A expenses
(b)
|
13,360
|
|
14,448
|
|
14,503
|
|
(7.5
|
)
|
(0.4
|
)
|
|||
|
EBITDA
|
7,263
|
|
7,340
|
|
6,837
|
|
(1.1
|
)
|
7.4
|
|
|||
|
Depreciation and amortization
|
2,298
|
|
2,213
|
|
2,129
|
|
3.8
|
|
3.9
|
|
|||
|
EBIT
|
$
|
4,965
|
|
$
|
5,127
|
|
$
|
4,708
|
|
(3.2
|
)%
|
8.9
|
%
|
|
(a)
|
Sales include $3,815 million and $4,148 million related to our former pharmacy and clinic businesses for 2015 and 2014, respectively, and cost of sales include $3,076 million and $3,222 million, respectively. The sale of these businesses had no notable impact on EBITDA or EBIT.
|
|
(b)
|
For 2016, 2015, and 2014, SG&A includes $663 million, $641 million, and $629 million, respectively, of net profit-sharing income from the arrangement with TD.
|
|
Rate Analysis
|
2016
|
|
2015
|
|
2014
|
|
|
Gross margin rate
|
29.7
|
%
|
29.5
|
%
|
29.4
|
%
|
|
SG&A expense rate
|
19.2
|
|
19.6
|
|
20.0
|
|
|
EBITDA margin rate
(a)
|
10.5
|
|
9.9
|
|
9.4
|
|
|
Depreciation and amortization expense rate
|
3.3
|
|
3.0
|
|
2.9
|
|
|
EBIT margin rate
(a)
|
7.1
|
|
6.9
|
|
6.5
|
|
|
(a)
|
Excluding sales of our former pharmacy and clinic businesses, EBITDA margin rates were 10.5 percent and 10.0 percent for 2015 and 2014, respectively. and EBIT margin rates were 7.3 percent and 6.9 percent, respectively.
|
|
Sales by Channel
|
2016
|
|
2015
(a)
|
|
2014
(a)
|
|
|
Stores
|
95.6
|
%
|
96.6
|
%
|
97.4
|
%
|
|
Digital
|
4.4
|
|
3.4
|
|
2.6
|
|
|
Total
|
100
|
%
|
100
|
%
|
100
|
%
|
|
(a)
|
Excluding sales of our former pharmacy and clinic businesses, stores and digital channels sales were 96.4 percent and 3.6 percent of total sales, respectively, for 2015 and 97.2 and 2.8 percent of total sales, respectively, for 2014.
|
|
Comparable Sales
|
2016
|
|
2015
|
|
2014
|
|
|
Comparable sales change
|
(0.5
|
)%
|
2.1
|
%
|
1.3
|
%
|
|
Drivers of change in comparable sales:
|
|
|
|
|||
|
Number of transactions
|
(0.8
|
)
|
1.3
|
|
(0.2
|
)
|
|
Average transaction amount
|
0.3
|
|
0.8
|
|
1.5
|
|
|
Contribution to Comparable Sales Change
|
2016
|
|
2015
|
|
2014
|
|
|
Stores channel comparable sales change
|
(1.5
|
)%
|
1.3
|
%
|
0.7
|
%
|
|
Digital channel contribution to comparable sales change
|
1.0
|
|
0.8
|
|
0.7
|
|
|
Total comparable sales change
|
(0.5
|
)%
|
2.1
|
%
|
1.3
|
%
|
|
Sales by Product Category
|
Percentage of Sales
|
|||||
|
|
2016
|
|
2015
|
|
2014
|
|
|
Household essentials
(a)
|
22
|
%
|
26
|
%
|
25
|
%
|
|
Food, beverage, and pet supplies
(b)
|
22
|
|
21
|
|
21
|
|
|
Apparel and accessories
(c)
|
20
|
|
19
|
|
19
|
|
|
Home furnishings and décor
(d)
|
19
|
|
17
|
|
17
|
|
|
Hardlines
(e)
|
17
|
|
17
|
|
18
|
|
|
Total
|
100
|
%
|
100
|
%
|
100
|
%
|
|
(a)
|
Includes pharmacy, beauty, personal care, baby care, cleaning, and paper products. Pharmacy represented 5 percent and 6 percent in 2015 and 2014, respectively.
|
|
(b)
|
Includes dry grocery, dairy, frozen food, beverages, candy, snacks, deli, bakery, meat, produce, and pet supplies.
|
|
(c)
|
Includes apparel for women, men, boys, girls, toddlers, infants and newborns, as well as intimate apparel, jewelry, accessories, and shoes.
|
|
(d)
|
Includes furniture, lighting, kitchenware, small appliances, home décor, bed and bath, home improvement, automotive, and seasonal merchandise such as patio furniture and holiday décor.
|
|
(e)
|
Includes electronics (including video game hardware and software), music, movies, books, computer software, sporting goods, and toys.
|
|
REDcard Penetration
|
2016
|
|
2015
|
|
2014
|
|
|
Target Debit Card
|
12.8
|
%
|
12.1
|
%
|
11.2
|
%
|
|
Target Credit Cards
|
11.2
|
|
10.1
|
|
9.7
|
|
|
Total REDcard Penetration
|
24.0
|
%
|
22.3
|
%
|
20.9
|
%
|
|
Change in Number of Stores
|
2016
|
|
2015
|
|
|
Beginning store count
|
1,792
|
|
1,790
|
|
|
Opened
|
15
|
|
15
|
|
|
Closed
|
(5
|
)
|
(13
|
)
|
|
Ending store count
|
1,802
|
|
1,792
|
|
|
Number of Stores and
Retail Square Feet |
Number of Stores
|
|
Retail Square Feet
(a)
|
||||||
|
January 28, 2017
|
|
January 30, 2016
|
|
|
January 28, 2017
|
|
January 30, 2016
|
|
|
|
170,000 or more sq. ft.
|
276
|
|
278
|
|
|
49,328
|
|
49,688
|
|
|
50,000 to 169,999 sq. ft.
|
1,504
|
|
1,505
|
|
|
189,620
|
|
189,677
|
|
|
49,999 or less sq. ft.
|
22
|
|
9
|
|
|
554
|
|
174
|
|
|
Total
|
1,802
|
|
1,792
|
|
|
239,502
|
|
239,539
|
|
|
(a)
|
In thousands, reflects total square feet less office, distribution center and vacant space.
|
|
|
|
2016
|
|
2015
|
|
2014
|
||||||||||||||||||||||||||||||
|
(millions, except per share data)
|
|
Pretax
|
|
|
Net of Tax
|
|
|
Per Share Amounts
|
|
|
Pretax
|
|
|
Net of Tax
|
|
|
Per Share Amounts
|
|
|
Pretax
|
|
|
Net of Tax
|
|
|
Per Share Amounts
|
|
|||||||||
|
GAAP diluted earnings per share from continuing operations
|
|
|
|
|
|
$
|
4.58
|
|
|
|
|
|
|
$
|
5.25
|
|
|
|
|
|
|
$
|
3.83
|
|
||||||||||||
|
Adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Loss on early retirement of debt
|
|
$
|
422
|
|
|
$
|
257
|
|
|
$
|
0.44
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
285
|
|
|
$
|
173
|
|
|
$
|
0.27
|
|
|
Gain on sale
(a)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(620
|
)
|
|
(487
|
)
|
|
(0.77
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Restructuring costs
(b)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
138
|
|
|
87
|
|
|
0.14
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Data breach-related costs, net of insurance
(c)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
39
|
|
|
28
|
|
|
0.04
|
|
|
145
|
|
|
94
|
|
|
0.15
|
|
|||||||||
|
Other
(d)
|
|
(4
|
)
|
|
(2
|
)
|
|
—
|
|
|
39
|
|
|
29
|
|
|
0.05
|
|
|
29
|
|
|
18
|
|
|
0.03
|
|
|||||||||
|
Resolution of income tax matters
|
|
—
|
|
|
(7
|
)
|
|
(0.01
|
)
|
|
—
|
|
|
(8
|
)
|
|
(0.01
|
)
|
|
—
|
|
|
(35
|
)
|
|
(0.06
|
)
|
|||||||||
|
Adjusted diluted earnings per share from continuing operations
|
|
|
|
|
|
$
|
5.01
|
|
|
|
|
|
|
$
|
4.69
|
|
|
|
|
|
|
$
|
4.22
|
|
||||||||||||
|
(a)
|
Refer to Note
6
of the Financial Statements.
|
|
(b)
|
Refer to Note
8
of the Financial Statements.
|
|
(c)
|
Refer to Note
19
of the Financial Statements.
|
|
(d)
|
For 2016, represents items related to the Pharmacy Transaction. For 2015, represents impairments related to our decision to wind down certain noncore operations, as described in Note
16
of the Financial Statements. The 2014 amounts include impairments of $16 million related to undeveloped land in the U.S. and $13 million of expense related to converting co-branded card program to MasterCard.
|
|
After-Tax Return on Invested Capital
|
|
|
||||||||||
|
|
|
|
|
|
||||||||
|
Numerator
|
|
Trailing Twelve Months
|
|
|
||||||||
|
(dollars in millions)
|
|
January 28,
2017 |
|
|
January 30,
2016 |
|
|
|
||||
|
Earnings from continuing operations before interest expense and income taxes
|
|
$
|
4,969
|
|
|
$
|
5,530
|
|
|
|
||
|
+ Operating lease interest
(a)(b)
|
|
71
|
|
|
87
|
|
|
|
||||
|
Adjusted earnings from continuing operations before interest expense and income taxes
|
|
5,040
|
|
|
5,617
|
|
|
|
||||
|
- Income taxes
(c)
|
|
1,648
|
|
|
1,827
|
|
|
|
||||
|
Net operating profit after taxes
|
|
$
|
3,392
|
|
|
$
|
3,790
|
|
|
|
||
|
Denominator
(dollars in millions)
|
|
January 28,
2017 |
|
|
January 30,
2016 |
|
|
January 31,
2015 |
|
|||
|
Current portion of long-term debt and other borrowings
|
|
$
|
1,718
|
|
|
$
|
815
|
|
|
$
|
91
|
|
|
+ Noncurrent portion of long-term debt
|
|
11,031
|
|
|
11,945
|
|
|
12,634
|
|
|||
|
+ Shareholders' equity
|
|
10,953
|
|
|
12,957
|
|
|
13,997
|
|
|||
|
+ Capitalized operating lease obligations
(b)(d)
|
|
1,187
|
|
|
1,457
|
|
|
1,490
|
|
|||
|
- Cash and cash equivalents
|
|
2,512
|
|
|
4,046
|
|
|
2,210
|
|
|||
|
- Net assets of discontinued operations
|
|
62
|
|
|
226
|
|
|
1,479
|
|
|||
|
Invested capital
|
|
$
|
22,315
|
|
|
$
|
22,902
|
|
|
$
|
24,523
|
|
|
Average invested capital
(e)
|
|
$
|
22,608
|
|
|
$
|
23,713
|
|
|
|
||
|
After-tax return on invested capital
|
|
15.0
|
%
|
|
16.0
|
%
|
(f)
|
|
|
(a)
|
Represents the add-back to operating income driven by the hypothetical interest expense we would incur if the property under our operating leases were owned or accounted for as capital leases, using eight times our trailing twelve months rent expense and an estimated interest rate of six percent.
|
|
(b)
|
See the following Reconciliation of Capitalized Operating Leases table for the adjustments to our GAAP total rent expense to obtain the hypothetical capitalization of operating leases and related operating lease interest.
|
|
(c)
|
Calculated using the effective tax rate for continuing operations, which was
32.7
percent and
32.5
percent for the trailing twelve months ended
January 28, 2017
and
January 30, 2016
. For the twelve months ended January 28, 2017 and January 30, 2016, includes tax effect of $1,624 million and $1,799 million, respectively, related to EBIT and $23 million and $28 million, respectively, related to operating lease interest.
|
|
(d)
|
Calculated as eight times our trailing twelve months rent expense.
|
|
(e)
|
Average based on the invested capital at the end of the current period and the invested capital at the end of the prior period.
|
|
(f)
|
Excluding the net gain on the Pharmacy Transaction, ROIC was 13.9 percent for the trailing twelve months ended January 30, 2016.
|
|
Reconciliation of Capitalized Operating Leases
|
|
Trailing Twelve Months
|
||||||||||||
|
(dollars in millions)
|
|
January 28,
2017 |
|
|
January 30,
2016 |
|
|
January 31,
2015 |
|
|||||
|
Total rent expense
|
|
$
|
148
|
|
|
$
|
182
|
|
|
$
|
186
|
|
||
|
Capitalized operating lease obligations (total rent expense x 8)
|
|
1,187
|
|
|
1,457
|
|
|
1,490
|
|
|||||
|
Operating lease interest (capitalized operating lease obligations x 6%)
|
|
71
|
|
|
87
|
|
|
n/a
|
|
|||||
|
Credit Ratings
|
Moody's
|
Standard and Poor's
|
Fitch
|
|
Long-term debt
|
A2
|
A
|
A-
|
|
Commercial paper
|
P-1
|
A-1
|
F2
|
|
Commercial Paper
|
|
|
|
||||||
|
(dollars in millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Maximum daily amount outstanding during the year
|
$
|
89
|
|
$
|
—
|
|
$
|
590
|
|
|
Average amount outstanding during the year
|
1
|
|
—
|
|
129
|
|
|||
|
Amount outstanding at year-end
|
—
|
|
—
|
|
—
|
|
|||
|
Weighted average interest rate
|
0.43
|
%
|
—
|
%
|
0.11
|
%
|
|||
|
Contractual Obligations as of
|
Payments Due by Period
|
||||||||||||||
|
January 28, 2017
|
|
Less than
|
|
1-3
|
|
3-5
|
|
After 5
|
|
||||||
|
(millions)
|
Total
|
|
1 Year
|
|
Years
|
|
Years
|
|
Years
|
|
|||||
|
Recorded contractual obligations:
|
|
|
|
|
|
||||||||||
|
Long-term debt
(a)
|
$
|
11,814
|
|
$
|
1,683
|
|
$
|
1,203
|
|
$
|
2,150
|
|
$
|
6,778
|
|
|
Capital lease obligations
(b)
|
1,963
|
|
82
|
|
174
|
|
178
|
|
1,529
|
|
|||||
|
Deferred compensation
(c)
|
515
|
|
56
|
|
114
|
|
121
|
|
224
|
|
|||||
|
Real estate liabilities
(d)
|
52
|
|
52
|
|
—
|
|
—
|
|
—
|
|
|||||
|
Tax contingencies
(e)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|||||
|
Unrecorded contractual obligations:
|
|
|
|
|
|
||||||||||
|
Interest payments – long-term debt
|
6,308
|
|
510
|
|
819
|
|
710
|
|
4,269
|
|
|||||
|
Operating leases
(b)
|
3,876
|
|
198
|
|
398
|
|
364
|
|
2,916
|
|
|||||
|
Purchase obligations
(f)
|
1,762
|
|
609
|
|
814
|
|
107
|
|
232
|
|
|||||
|
Real estate obligations
(g)
|
216
|
|
185
|
|
31
|
|
—
|
|
—
|
|
|||||
|
Future contributions to retirement plans
(h)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|||||
|
Contractual obligations
|
$
|
26,506
|
|
$
|
3,375
|
|
$
|
3,553
|
|
$
|
3,630
|
|
$
|
15,948
|
|
|
(a)
|
Represents principal payments only. See Note
20
of the Financial Statements for further information.
|
|
(b)
|
These payments also include $348 million and $269 million of legally binding minimum lease payments for stores that are expected to open in
2017
or later for capital and operating leases, respectively. See Note
22
of the Financial Statements for further information.
|
|
(c)
|
The timing of deferred compensation payouts is estimated based on payments currently made to former employees and retirees, forecasted investment returns, and the projected timing of future retirements.
|
|
(d)
|
Real estate liabilities include costs incurred but not paid related to the construction or remodeling of real estate and facilities.
|
|
(e)
|
Estimated tax contingencies of $222 million, including interest and penalties and primarily related to continuing operations, are not included in the table above because we are not able to make reasonably reliable estimates of the period of cash settlement. See Note
23
of the Financial Statements for further information.
|
|
(f)
|
Purchase obligations include all legally binding contracts such as firm minimum commitments for inventory purchases, merchandise royalties, equipment purchases, marketing-related contracts, software acquisition/license commitments, and service contracts. We issue inventory purchase orders in the normal course of business, which represent authorizations to purchase that are cancelable by their terms. We do not consider purchase orders to be firm inventory commitments; therefore, they are excluded from the table above. If we choose to cancel a purchase order, we may be obligated to reimburse the vendor for unrecoverable outlays incurred prior to cancellation. We also issue trade letters of credit in the ordinary course of business, which are excluded from this table as these obligations are conditioned on terms of the letter of credit being met.
|
|
(g)
|
Real estate obligations include commitments for the purchase, construction, or remodeling of real estate and facilities.
|
|
(h)
|
We have not included obligations under our pension plans in the contractual obligations table above because no additional amounts are required to be funded as of
January 28, 2017
. Our historical practice regarding these plans has been to contribute amounts necessary to satisfy minimum pension funding requirements, plus periodic discretionary amounts determined to be appropriate.
|
|
|
|
|
Brian C. Cornell
Chairman and Chief Executive Officer
March 8, 2017
|
|
Cathy R. Smith
Executive Vice President and
Chief Financial Officer
|
|
|
|
|
|
Minneapolis, Minnesota
March 8, 2017
|
|
|
|
|
|
Brian C. Cornell
Chairman and Chief Executive Officer
March 8, 2017 |
|
Cathy R. Smith
Executive Vice President and Chief Financial Officer |
|
|
|
|
|
Minneapolis, Minnesota March 8, 2017 |
|
|
(millions, except per share data)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Sales
|
$
|
69,495
|
|
$
|
73,785
|
|
$
|
72,618
|
|
|
Cost of sales
|
48,872
|
|
51,997
|
|
51,278
|
|
|||
|
Gross margin
|
20,623
|
|
21,788
|
|
21,340
|
|
|||
|
Selling, general and administrative expenses
|
13,356
|
|
14,665
|
|
14,676
|
|
|||
|
Depreciation and amortization
|
2,298
|
|
2,213
|
|
2,129
|
|
|||
|
Gain on sale
|
—
|
|
(620
|
)
|
—
|
|
|||
|
Earnings from continuing operations before interest expense and income taxes
|
4,969
|
|
5,530
|
|
4,535
|
|
|||
|
Net interest expense
|
1,004
|
|
607
|
|
882
|
|
|||
|
Earnings from continuing operations before income taxes
|
3,965
|
|
4,923
|
|
3,653
|
|
|||
|
Provision for income taxes
|
1,296
|
|
1,602
|
|
1,204
|
|
|||
|
Net earnings from continuing operations
|
2,669
|
|
3,321
|
|
2,449
|
|
|||
|
Discontinued operations, net of tax
|
68
|
|
42
|
|
(4,085
|
)
|
|||
|
Net earnings
/
(loss)
|
$
|
2,737
|
|
$
|
3,363
|
|
$
|
(1,636
|
)
|
|
Basic earnings
/
(loss) per share
|
|
|
|
||||||
|
Continuing operations
|
$
|
4.62
|
|
$
|
5.29
|
|
$
|
3.86
|
|
|
Discontinued operations
|
0.12
|
|
0.07
|
|
(6.44
|
)
|
|||
|
Net earnings
/
(loss) per share
|
$
|
4.74
|
|
$
|
5.35
|
|
$
|
(2.58
|
)
|
|
Diluted earnings
/
(loss) per share
|
|
|
|
||||||
|
Continuing operations
|
$
|
4.58
|
|
$
|
5.25
|
|
$
|
3.83
|
|
|
Discontinued operations
|
0.12
|
|
0.07
|
|
(6.38
|
)
|
|||
|
Net earnings
/
(loss) per share
|
$
|
4.70
|
|
$
|
5.31
|
|
$
|
(2.56
|
)
|
|
Weighted average common shares outstanding
|
|
|
|
||||||
|
Basic
|
577.6
|
|
627.7
|
|
634.7
|
|
|||
|
Dilutive effect of share-based awards
|
4.9
|
|
5.2
|
|
5.4
|
|
|||
|
Diluted
|
582.5
|
|
632.9
|
|
640.1
|
|
|||
|
Antidilutive shares
|
0.1
|
|
—
|
|
3.3
|
|
|||
|
Dividends declared per share
|
$
|
2.36
|
|
$
|
2.20
|
|
$
|
1.99
|
|
|
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Net income
/
(loss)
|
$
|
2,737
|
|
$
|
3,363
|
|
$
|
(1,636
|
)
|
|
Other comprehensive (loss)
/
income, net of tax
|
|
|
|
||||||
|
Pension and other benefit liabilities, net of tax benefit of $9, $18, and $90
|
(13
|
)
|
(27
|
)
|
(139
|
)
|
|||
|
Currency translation adjustment and cash flow hedges, net of provision for taxes of $2, $2, and $2
|
4
|
|
(3
|
)
|
431
|
|
|||
|
Other comprehensive (loss)
/
income
|
(9
|
)
|
(30
|
)
|
292
|
|
|||
|
Comprehensive income
/
(loss)
|
$
|
2,728
|
|
$
|
3,333
|
|
$
|
(1,344
|
)
|
|
(millions, except footnotes)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
Assets
|
|
|
||||
|
Cash and cash equivalents, including short-term investments of $1,110 and $3,008
|
$
|
2,512
|
|
$
|
4,046
|
|
|
Inventory
|
8,309
|
|
8,601
|
|
||
|
Assets of discontinued operations
|
69
|
|
322
|
|
||
|
Other current assets
|
1,100
|
|
1,161
|
|
||
|
Total current assets
|
11,990
|
|
14,130
|
|
||
|
Property and equipment
|
|
|
||||
|
Land
|
6,106
|
|
6,125
|
|
||
|
Buildings and improvements
|
27,611
|
|
27,059
|
|
||
|
Fixtures and equipment
|
5,503
|
|
5,347
|
|
||
|
Computer hardware and software
|
2,651
|
|
2,617
|
|
||
|
Construction-in-progress
|
200
|
|
315
|
|
||
|
Accumulated depreciation
|
(17,413
|
)
|
(16,246
|
)
|
||
|
Property and equipment, net
|
24,658
|
|
25,217
|
|
||
|
Noncurrent assets of discontinued operations
|
12
|
|
75
|
|
||
|
Other noncurrent assets
|
771
|
|
840
|
|
||
|
Total assets
|
$
|
37,431
|
|
$
|
40,262
|
|
|
Liabilities and shareholders' investment
|
|
|
||||
|
Accounts payable
|
$
|
7,252
|
|
$
|
7,418
|
|
|
Accrued and other current liabilities
|
3,737
|
|
4,236
|
|
||
|
Current portion of long-term debt and other borrowings
|
1,718
|
|
815
|
|
||
|
Liabilities of discontinued operations
|
1
|
|
153
|
|
||
|
Total current liabilities
|
12,708
|
|
12,622
|
|
||
|
Long-term debt and other borrowings
|
11,031
|
|
11,945
|
|
||
|
Deferred income taxes
|
861
|
|
823
|
|
||
|
Noncurrent liabilities of discontinued operations
|
18
|
|
18
|
|
||
|
Other noncurrent liabilities
|
1,860
|
|
1,897
|
|
||
|
Total noncurrent liabilities
|
13,770
|
|
14,683
|
|
||
|
Shareholders' investment
|
|
|
||||
|
Common stock
|
46
|
|
50
|
|
||
|
Additional paid-in capital
|
5,661
|
|
5,348
|
|
||
|
Retained earnings
|
5,884
|
|
8,188
|
|
||
|
Accumulated other comprehensive loss
|
|
|
||||
|
Pension and other benefit liabilities
|
(601
|
)
|
(588
|
)
|
||
|
Currency translation adjustment and cash flow hedges
|
(37
|
)
|
(41
|
)
|
||
|
Total shareholders' investment
|
10,953
|
|
12,957
|
|
||
|
Total liabilities and shareholders' investment
|
$
|
37,431
|
|
$
|
40,262
|
|
|
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Operating activities
|
|
|
|
||||||
|
Net earnings
/
(loss)
|
$
|
2,737
|
|
$
|
3,363
|
|
$
|
(1,636
|
)
|
|
Earnings
/
(losses) from discontinued operations, net of tax
|
68
|
|
42
|
|
(4,085
|
)
|
|||
|
Net earnings from continuing operations
|
2,669
|
|
3,321
|
|
2,449
|
|
|||
|
Adjustments to reconcile net earnings to cash provided by operations:
|
|
|
|
||||||
|
Depreciation and amortization
|
2,298
|
|
2,213
|
|
2,129
|
|
|||
|
Share-based compensation expense
|
113
|
|
115
|
|
71
|
|
|||
|
Deferred income taxes
|
41
|
|
(322
|
)
|
7
|
|
|||
|
Gain on sale
|
—
|
|
(620
|
)
|
—
|
|
|||
|
Loss on debt extinguishment
|
422
|
|
—
|
|
285
|
|
|||
|
Noncash (gains)
/
losses and other, net
|
—
|
|
57
|
|
40
|
|
|||
|
Changes in operating accounts:
|
|
|
|
||||||
|
Inventory
|
293
|
|
(316
|
)
|
(512
|
)
|
|||
|
Other assets
|
36
|
|
227
|
|
(115
|
)
|
|||
|
Accounts payable and accrued liabilities
|
(543
|
)
|
579
|
|
803
|
|
|||
|
Cash provided by operating activities—continuing operations
|
5,329
|
|
5,254
|
|
5,157
|
|
|||
|
Cash provided by
/
(
required for) operating activities—discontinued operations
|
107
|
|
704
|
|
(692
|
)
|
|||
|
Cash provided by operations
|
5,436
|
|
5,958
|
|
4,465
|
|
|||
|
Investing activities
|
|
|
|
||||||
|
Expenditures for property and equipment
|
(1,547
|
)
|
(1,438
|
)
|
(1,786
|
)
|
|||
|
Proceeds from disposal of property and equipment
|
46
|
|
28
|
|
95
|
|
|||
|
Proceeds from sale of businesses
|
—
|
|
1,875
|
|
—
|
|
|||
|
Cash paid for acquisitions, net of cash assumed
|
—
|
|
—
|
|
(20
|
)
|
|||
|
Other investments
|
28
|
|
24
|
|
106
|
|
|||
|
Cash (required for)
/
provided by investing activities—continuing operations
|
(1,473
|
)
|
489
|
|
(1,605
|
)
|
|||
|
Cash provided by
/
(
required for) investing activities—discontinued operations
|
—
|
|
19
|
|
(321
|
)
|
|||
|
Cash
(
required for)
/
provided by investing activities
|
(1,473
|
)
|
508
|
|
(1,926
|
)
|
|||
|
Financing activities
|
|
|
|
||||||
|
Change in commercial paper, net
|
—
|
|
—
|
|
(80
|
)
|
|||
|
Additions to long-term debt
|
1,977
|
|
—
|
|
1,993
|
|
|||
|
Reductions of long-term debt
|
(2,641
|
)
|
(85
|
)
|
(2,079
|
)
|
|||
|
Dividends paid
|
(1,348
|
)
|
(1,362
|
)
|
(1,205
|
)
|
|||
|
Repurchase of stock
|
(3,706
|
)
|
(3,483
|
)
|
(26
|
)
|
|||
|
Stock option exercises
|
221
|
|
300
|
|
373
|
|
|||
|
Cash required for financing activities
|
(5,497
|
)
|
(4,630
|
)
|
(1,024
|
)
|
|||
|
Net (decrease)
/
increase in cash and cash equivalents
|
(1,534
|
)
|
1,836
|
|
1,515
|
|
|||
|
Cash and cash equivalents at beginning of period
(a)
|
4,046
|
|
2,210
|
|
695
|
|
|||
|
Cash and cash equivalents at end of period
|
$
|
2,512
|
|
$
|
4,046
|
|
$
|
2,210
|
|
|
Supplemental information
|
|
|
|
||||||
|
Interest paid, net of capitalized interest
|
$
|
999
|
|
$
|
604
|
|
$
|
871
|
|
|
Income taxes paid / (refunded)
|
1,514
|
|
(127
|
)
|
1,251
|
|
|||
|
Property and equipment acquired through capital lease obligations
|
238
|
|
126
|
|
88
|
|
|||
|
(millions)
|
Common
Stock
Shares
|
|
Stock
Par
Value
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated Other
Comprehensive
(Loss)
/
Income
|
|
Total
|
|
|||||
|
February 1, 2014
|
632.9
|
|
$
|
53
|
|
$
|
4,470
|
|
$
|
12,599
|
|
$
|
(891
|
)
|
$
|
16,231
|
|
|
Net loss
|
—
|
|
—
|
|
—
|
|
(1,636
|
)
|
—
|
|
(1,636
|
)
|
|||||
|
Other comprehensive income
|
—
|
|
—
|
|
—
|
|
—
|
|
292
|
|
292
|
|
|||||
|
Dividends declared
|
—
|
|
—
|
|
—
|
|
(1,273
|
)
|
—
|
|
(1,273
|
)
|
|||||
|
Repurchase of stock
|
(0.8
|
)
|
—
|
|
—
|
|
(46
|
)
|
—
|
|
(46
|
)
|
|||||
|
Stock options and awards
|
8.1
|
|
—
|
|
429
|
|
—
|
|
—
|
|
429
|
|
|||||
|
January 31, 2015
|
640.2
|
|
$
|
53
|
|
$
|
4,899
|
|
$
|
9,644
|
|
$
|
(599
|
)
|
$
|
13,997
|
|
|
Net earnings
|
—
|
|
—
|
|
—
|
|
3,363
|
|
—
|
|
3,363
|
|
|||||
|
Other comprehensive loss
|
—
|
|
—
|
|
—
|
|
—
|
|
(30
|
)
|
(30
|
)
|
|||||
|
Dividends declared
|
—
|
|
—
|
|
—
|
|
(1,378
|
)
|
—
|
|
(1,378
|
)
|
|||||
|
Repurchase of stock
|
(44.7
|
)
|
(4
|
)
|
—
|
|
(3,441
|
)
|
—
|
|
(3,445
|
)
|
|||||
|
Stock options and awards
|
6.7
|
|
1
|
|
449
|
|
—
|
|
—
|
|
450
|
|
|||||
|
January 30, 2016
|
602.2
|
|
$
|
50
|
|
$
|
5,348
|
|
$
|
8,188
|
|
$
|
(629
|
)
|
$
|
12,957
|
|
|
Net earnings
|
—
|
|
—
|
|
—
|
|
2,737
|
|
—
|
|
2,737
|
|
|||||
|
Other comprehensive loss
|
—
|
|
—
|
|
—
|
|
—
|
|
(9
|
)
|
(9
|
)
|
|||||
|
Dividends declared
|
—
|
|
—
|
|
—
|
|
(1,359
|
)
|
—
|
|
(1,359
|
)
|
|||||
|
Repurchase of stock
|
(50.9
|
)
|
(4
|
)
|
—
|
|
(3,682
|
)
|
—
|
|
(3,686
|
)
|
|||||
|
Stock options and awards
|
4.9
|
|
—
|
|
313
|
|
—
|
|
—
|
|
313
|
|
|||||
|
January 28, 2017
|
556.2
|
|
$
|
46
|
|
$
|
5,661
|
|
$
|
5,884
|
|
$
|
(638
|
)
|
$
|
10,953
|
|
|
Cost of Sales
|
Selling, General and Administrative Expenses
|
|
Total cost of products sold including
• Freight expenses associated with moving
merchandise from our vendors to and between our
distribution centers and our retail stores
• Vendor income that is not reimbursement of
specific, incremental, and identifiable costs
Inventory shrink
Markdowns
Outbound shipping and handling expenses
associated with sales to our guests
Payment term cash discounts
Distribution center costs, including compensation
and benefits costs
Import costs
|
Compensation and benefit costs for stores and
headquarters Occupancy and operating costs of retail and headquarters facilities Advertising, offset by vendor income that is a reimbursement of specific, incremental, and identifiable costs Pre-opening costs of stores and other facilities U.S. credit cards servicing expenses and profit sharing Costs associated with accepting 3 rd party bank issued payment cards Litigation and defense costs and related insurance recovery Other administrative costs |
|
Advertising Costs
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Gross advertising costs
|
$
|
1,503
|
|
$
|
1,472
|
|
$
|
1,647
|
|
|
Vendor income
|
(38
|
)
|
(38
|
)
|
(47
|
)
|
|||
|
Net advertising costs
|
$
|
1,465
|
|
$
|
1,434
|
|
$
|
1,600
|
|
|
Gain on Pharmacy Transaction
(millions)
|
2015
|
|
|
|
Cash consideration
|
$
|
1,868
|
|
|
Less:
|
|
||
|
Deferred income
(a)
|
694
|
|
|
|
Inventory
|
447
|
|
|
|
Other assets
|
13
|
|
|
|
Pretax transaction costs and contingent liabilities
(b)
|
94
|
|
|
|
Pretax gain on Pharmacy Transaction
(c)
|
$
|
620
|
|
|
(a)
|
Represents the consideration received at the close of the sale related to CVS’s leasehold interest in the related space within our stores. Deferred income will be recorded as a reduction to SG&A expense evenly over the
23
-year weighted average remaining accounting useful life of our stores. As of
January 28, 2017
,
$660 million
remains in other current and other noncurrent liabilities.
|
|
(b)
|
Primarily relates to professional services, contract termination charges, severance, and impairment of certain assets not sold to CVS.
|
|
(c)
|
Recorded outside of segment results and excluded from Adjusted EPS.
|
|
Income
/
(Loss) on Discontinued Operations
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Sales
|
$
|
—
|
|
$
|
—
|
|
$
|
1,902
|
|
|
Cost of sales
|
—
|
|
—
|
|
1,541
|
|
|||
|
SG&A expenses
|
—
|
|
—
|
|
909
|
|
|||
|
Depreciation and amortization
|
—
|
|
—
|
|
248
|
|
|||
|
Interest expense
|
—
|
|
—
|
|
73
|
|
|||
|
Pretax loss from operations
|
—
|
|
—
|
|
(869
|
)
|
|||
|
Pretax exit costs
|
13
|
|
(129
|
)
|
(5,105
|
)
|
|||
|
Income taxes
|
55
|
|
171
|
|
1,889
|
|
|||
|
Income
/
(loss) from discontinued operations
|
$
|
68
|
|
$
|
42
|
|
$
|
(4,085
|
)
|
|
Pretax Exit Costs
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Investment impairment
|
$
|
(222
|
)
|
$
|
(6
|
)
|
$
|
(4,766
|
)
|
|
Contingent liabilities
|
229
|
|
(62
|
)
|
(240
|
)
|
|||
|
Other exit costs
|
6
|
|
(61
|
)
|
(99
|
)
|
|||
|
Total
|
$
|
13
|
|
$
|
(129
|
)
|
$
|
(5,105
|
)
|
|
Assets and Liabilities of Discontinued Operations
(millions)
|
January 28,
2017 |
|
|
January 30,
2016 |
|
||
|
Income tax benefit
|
$
|
35
|
|
|
$
|
77
|
|
|
Receivables from Canada Subsidiaries
(a)
|
46
|
|
|
320
|
|
||
|
Total assets
|
$
|
81
|
|
|
$
|
397
|
|
|
|
|
|
|
||||
|
Accrued liabilities
|
$
|
19
|
|
|
$
|
171
|
|
|
Total liabilities
|
$
|
19
|
|
|
$
|
171
|
|
|
(a)
|
Represents loans and accounts receivable from Canada Subsidiaries.
|
|
Fair Value Measurements - Recurring Basis
|
|
Fair Value at
|
||||||
|
(millions)
|
Pricing Category
|
January 28,
2017 |
|
|
January 30,
2016 |
|
||
|
Assets
|
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
|
|
|
|
|
|
||
|
Short-term investments
|
Level 1
|
$
|
1,110
|
|
|
$
|
3,008
|
|
|
Other current assets
|
|
|
|
|
|
|
||
|
Interest rate swaps
(a)
|
Level 2
|
1
|
|
|
12
|
|
||
|
Prepaid forward contracts
|
Level 1
|
26
|
|
|
32
|
|
||
|
Beneficial interest asset
|
Level 3
|
12
|
|
|
19
|
|
||
|
Other noncurrent assets
|
|
|
|
|
|
|
||
|
Interest rate swaps
(a)
|
Level 2
|
4
|
|
|
27
|
|
||
|
Beneficial interest asset
|
Level 3
|
—
|
|
|
12
|
|
||
|
Liabilities
|
|
|
|
|
|
|
||
|
Other current liabilities
|
|
|
|
|
|
|
||
|
Interest rate swaps
(a)
|
Level 2
|
—
|
|
|
8
|
|
||
|
(a)
|
See Note
21
for additional information on interest rate swaps.
|
|
Valuation Technique
|
|
Short-term investments - Carrying value approximates fair value because maturities are less than three months.
|
|
Prepaid forward contracts - Initially valued at transaction price. Subsequently valued by reference to the market price of Target common stock.
|
|
Interest rate swaps - Valuation models are calibrated to initial trade price. Subsequent valuations are based on observable inputs to the valuation model (e.g., interest rates and credit spreads).
|
|
Significant Financial Instruments not Measured at Fair Value
(a)
(millions)
|
2016
|
|
2015
|
||||||||||
|
Carrying
Amount
|
|
Fair
Value
|
|
|
Carrying
Amount
|
|
Fair
Value
|
|
|||||
|
Debt
(b)
|
$
|
11,715
|
|
$
|
12,545
|
|
|
$
|
11,859
|
|
$
|
13,385
|
|
|
(a)
|
The carrying amounts of certain other current assets, accounts payable, and certain accrued and other current liabilities approximate fair value due to their short-term nature.
|
|
(b)
|
The fair value of debt is generally measured using a discounted cash flow analysis based on current market interest rates for the same or similar types of financial instruments and would be classified as Level 2. These amounts exclude unamortized swap valuation adjustments and capital lease obligations.
|
|
Other Current Assets
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
Vendor income receivable
|
$
|
385
|
|
$
|
384
|
|
|
Income tax and other receivables
|
364
|
|
352
|
|
||
|
Prepaid expenses
|
207
|
|
214
|
|
||
|
Other
|
144
|
|
211
|
|
||
|
Total
|
$
|
1,100
|
|
$
|
1,161
|
|
|
Estimated Useful Lives
|
Life (Years)
|
|
Buildings and improvements
|
8-39
|
|
Fixtures and equipment
|
2-15
|
|
Computer hardware and software
|
2-7
|
|
Impairments
(a)
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Impairments included in segment SG&A
|
$
|
43
|
|
$
|
50
|
|
$
|
108
|
|
|
Unallocated impairments
(b)
|
—
|
|
4
|
|
16
|
|
|||
|
Total impairments
|
$
|
43
|
|
$
|
54
|
|
$
|
124
|
|
|
(a)
|
Substantially all of the impairments are recorded in SG&A expense on the Consolidated Statements of Operations.
|
|
(b)
|
For 2015, represents long-lived asset impairments from our decision to wind down certain noncore operations. For 2014, represents impairments of undeveloped land. These costs were not included in our segment results.
|
|
Other Noncurrent Assets
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
Company-owned life insurance investments
(a)
|
$
|
345
|
|
$
|
308
|
|
|
Goodwill and intangible assets
|
259
|
|
277
|
|
||
|
Pension asset
|
43
|
|
66
|
|
||
|
Other
|
124
|
|
189
|
|
||
|
Total
|
$
|
771
|
|
$
|
840
|
|
|
(a)
|
Company-owned life insurance policies on approximately
4,000
team members who have been designated highly compensated under the Internal Revenue Code and have given their consent to be insured. Amounts are presented net of loans that are secured by some of these policies.
|
|
Intangible Assets
|
Leasehold
Acquisition Costs
|
|
Other
(a)
|
|
Total
|
|||||||||||||||
|
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
|
January 28,
2017 |
|
January 30,
2016 |
|
|
January 28,
2017 |
|
January 30,
2016 |
|
||||||
|
Gross asset
|
$
|
208
|
|
$
|
211
|
|
|
$
|
88
|
|
$
|
88
|
|
|
$
|
296
|
|
$
|
299
|
|
|
Accumulated amortization
|
(132
|
)
|
(127
|
)
|
|
(38
|
)
|
(27
|
)
|
|
(170
|
)
|
(154
|
)
|
||||||
|
Net intangible assets
|
$
|
76
|
|
$
|
84
|
|
|
$
|
50
|
|
$
|
61
|
|
|
$
|
126
|
|
$
|
145
|
|
|
(a)
|
Other intangible assets relate primarily to trademarks.
|
|
Estimated Amortization Expense
(millions)
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
|||||
|
Amortization expense
|
$
|
16
|
|
$
|
12
|
|
$
|
11
|
|
$
|
11
|
|
$
|
11
|
|
|
Accrued and Other Current Liabilities
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
Wages and benefits
|
$
|
812
|
|
$
|
884
|
|
|
Gift card liability, net of estimated breakage
|
693
|
|
644
|
|
||
|
Real estate, sales, and other taxes payable
|
571
|
|
574
|
|
||
|
Dividends payable
|
334
|
|
337
|
|
||
|
Straight-line rent accrual
(a)
|
271
|
|
262
|
|
||
|
Income tax payable
|
158
|
|
502
|
|
||
|
Workers' compensation and general liability
(b)
|
141
|
|
146
|
|
||
|
Interest payable
|
71
|
|
76
|
|
||
|
Other
|
686
|
|
811
|
|
||
|
Total
|
$
|
3,737
|
|
$
|
4,236
|
|
|
(a)
|
Straight-line rent accrual represents the amount of operating lease rent expense recorded that exceeds cash payments.
|
|
(b)
|
We retain a substantial portion of the risk related to general liability and workers' compensation claims. Liabilities associated with these losses include estimates of both claims filed and losses incurred but not yet reported. We estimate our ultimate cost based on analysis of historical data and actuarial estimates. General liability and workers' compensation liabilities are recorded at our estimate of their net present value.
|
|
Debt Maturities
|
January 28, 2017
|
||||
|
(dollars in millions)
|
Rate
(a)
|
|
Balance
|
|
|
|
Due 2017-2021
|
4.2
|
%
|
$
|
5,007
|
|
|
Due 2022-2026
|
3.2
|
|
2,048
|
|
|
|
Due 2027-2031
|
6.9
|
|
462
|
|
|
|
Due 2032-2036
|
6.4
|
|
496
|
|
|
|
Due 2037-2041
|
6.8
|
|
1,237
|
|
|
|
Due 2042-2046
|
3.8
|
|
2,465
|
|
|
|
Total notes and debentures
|
4.4
|
|
11,715
|
|
|
|
Swap valuation adjustments
|
|
|
9
|
|
|
|
Capital lease obligations
|
|
|
1,025
|
|
|
|
Less: Amounts due within one year
|
|
|
(1,718
|
)
|
|
|
Long-term debt
|
|
|
$
|
11,031
|
|
|
(a)
|
Reflects the weighted average stated interest rate as of year-end.
|
|
Required Principal Payments
(millions)
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
|||||
|
Total required principal payments
|
$
|
1,683
|
|
$
|
201
|
|
$
|
1,002
|
|
$
|
1,094
|
|
$
|
1,056
|
|
|
Commercial Paper
(dollars in millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Maximum daily amount outstanding during the year
|
$
|
89
|
|
$
|
—
|
|
$
|
590
|
|
|
Average amount outstanding during the year
|
1
|
|
—
|
|
129
|
|
|||
|
Amount outstanding at year-end
|
—
|
|
—
|
|
—
|
|
|||
|
Weighted average interest rate
|
0.43
|
%
|
—
|
%
|
0.11
|
%
|
|||
|
Outstanding Interest Rate Swap Summary
(a)
|
January 28, 2017
|
||||||
|
|
Designated
|
|
|
De-Designated
|
|
||
|
(dollars in millions)
|
Pay Floating
|
|
|
Pay Floating
|
|
||
|
Weighted average rate:
|
|
|
|
||||
|
Pay
|
3-month LIBOR
|
|
|
1-month LIBOR
|
|
||
|
Receive
|
1.8
|
%
|
|
1.3
|
%
|
||
|
Weighted average maturity
|
2.4 years
|
|
|
1.0 year
|
|
||
|
Notional
|
$
|
1,000
|
|
|
$
|
250
|
|
|
(a)
|
There are
two
designated swaps and
one
de-designated swap at
January 28, 2017
|
|
Classification and Fair Value
(millions)
|
Assets
|
|
Liabilities
|
||||||||||||
|
Classification
|
Jan 28,
2017 |
|
Jan 30,
2016 |
|
|
Classification
|
Jan 28,
2017 |
|
Jan 30,
2016 |
|
|||||
|
Designated:
|
Other noncurrent assets
|
$
|
4
|
|
$
|
27
|
|
|
N/A
|
$
|
—
|
|
$
|
—
|
|
|
De-designated:
|
Other current assets
|
1
|
|
12
|
|
|
Other current liabilities
|
—
|
|
8
|
|
||||
|
Total
|
|
$
|
5
|
|
$
|
39
|
|
|
|
$
|
—
|
|
$
|
8
|
|
|
Derivative Contracts – Effect on Results of Operations
(millions)
|
||||||||||
|
Type of Contract
|
Classification of (Income)/Expense
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Interest rate swaps
|
Net interest expense
|
$
|
(24
|
)
|
$
|
(36
|
)
|
$
|
(32
|
)
|
|
Rent Expense
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Rent expense
|
$
|
202
|
|
$
|
198
|
|
$
|
195
|
|
|
Rent income
(a)
|
(54
|
)
|
(16
|
)
|
(9
|
)
|
|||
|
Total rent expense
|
$
|
148
|
|
$
|
182
|
|
$
|
186
|
|
|
Future Minimum Lease Payments
(millions)
|
Operating Leases
(a)
|
|
Capital Leases
(b)
|
|
Rent Income
|
|
Total
|
|
||||
|
2017
|
$
|
198
|
|
$
|
82
|
|
$
|
(22
|
)
|
$
|
258
|
|
|
2018
|
204
|
|
86
|
|
(21
|
)
|
269
|
|
||||
|
2019
|
194
|
|
88
|
|
(20
|
)
|
262
|
|
||||
|
2020
|
184
|
|
89
|
|
(20
|
)
|
253
|
|
||||
|
2021
|
180
|
|
89
|
|
(19
|
)
|
250
|
|
||||
|
After 2021
|
2,916
|
|
1,529
|
|
(286
|
)
|
4,159
|
|
||||
|
Total future minimum lease payments
|
$
|
3,876
|
|
$
|
1,963
|
|
$
|
(388
|
)
|
$
|
5,451
|
|
|
Less: Interest
(c)
|
|
|
938
|
|
|
|
|
|
||||
|
Present value of future minimum capital lease payments
(d)
|
|
|
$
|
1,025
|
|
|
|
|
|
|||
|
(a)
|
Total contractual lease payments include
$2,024 million
related to options to extend lease terms that are reasonably assured of being exercised and also includes
$269 million
of legally binding minimum lease payments for stores that are expected to open in 2017 or later.
|
|
(b)
|
Capital lease payments include
$608 million
related to options to extend lease terms that are reasonably assured of being exercised and also includes
$348 million
of legally binding minimum lease payments for stores that are expected to open in 2017 or later.
|
|
(c)
|
Calculated using the interest rate at inception for each lease.
|
|
(d)
|
Includes the current portion of
$31 million
.
|
|
Tax Rate Reconciliation – Continuing Operations
|
2016
|
|
2015
|
|
2014
|
|
|
Federal statutory rate
|
35.0
|
%
|
35.0
|
%
|
35.0
|
%
|
|
State income taxes, net of the federal tax benefit
|
2.7
|
|
3.0
|
|
2.2
|
|
|
International
|
(2.6
|
)
|
(2.3
|
)
|
(2.3
|
)
|
|
Excess tax benefit related to share-based payments
(a)
|
(0.6
|
)
|
—
|
|
—
|
|
|
Change in valuation allowance
|
—
|
|
(2.3
|
)
|
—
|
|
|
Other
|
(1.8
|
)
|
(0.9
|
)
|
(1.9
|
)
|
|
Effective tax rate
|
32.7
|
%
|
32.5
|
%
|
33.0
|
%
|
|
Provision for Income Taxes
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Current:
|
|
|
|
||||||
|
Federal
|
$
|
1,108
|
|
$
|
1,652
|
|
$
|
1,074
|
|
|
State
|
141
|
|
265
|
|
116
|
|
|||
|
International
|
6
|
|
7
|
|
7
|
|
|||
|
Total current
|
1,255
|
|
1,924
|
|
1,197
|
|
|||
|
Deferred:
|
|
|
|
||||||
|
Federal
|
21
|
|
(272
|
)
|
(2
|
)
|
|||
|
State
|
21
|
|
(50
|
)
|
10
|
|
|||
|
International
|
(1
|
)
|
—
|
|
(1
|
)
|
|||
|
Total deferred
|
41
|
|
(322
|
)
|
7
|
|
|||
|
Total provision
|
$
|
1,296
|
|
$
|
1,602
|
|
$
|
1,204
|
|
|
Net Deferred Tax Asset/(Liability)
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
Gross deferred tax assets:
|
|
|
||||
|
Accrued and deferred compensation
|
$
|
455
|
|
$
|
476
|
|
|
Accruals and reserves not currently deductible
|
328
|
|
323
|
|
||
|
Self-insured benefits
|
178
|
|
199
|
|
||
|
Prepaid store-in-store lease income
|
258
|
|
270
|
|
||
|
Other
|
62
|
|
90
|
|
||
|
Total gross deferred tax assets
|
1,281
|
|
1,358
|
|
||
|
Gross deferred tax liabilities:
|
|
|
||||
|
Property and equipment
|
(1,822
|
)
|
(1,790
|
)
|
||
|
Inventory
|
(182
|
)
|
(190
|
)
|
||
|
Other
|
(102
|
)
|
(168
|
)
|
||
|
Total gross deferred tax liabilities
|
(2,106
|
)
|
(2,148
|
)
|
||
|
Total net deferred tax liability
|
$
|
(825
|
)
|
$
|
(790
|
)
|
|
Reconciliation of Liability for Unrecognized Tax Benefits
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Balance at beginning of period
|
$
|
153
|
|
$
|
155
|
|
$
|
183
|
|
|
Additions based on tax positions related to the current year
|
12
|
|
10
|
|
10
|
|
|||
|
Additions for tax positions of prior years
|
6
|
|
14
|
|
17
|
|
|||
|
Reductions for tax positions of prior years
|
(16
|
)
|
(26
|
)
|
(42
|
)
|
|||
|
Settlements
|
(2
|
)
|
—
|
|
(13
|
)
|
|||
|
Balance at end of period
|
$
|
153
|
|
$
|
153
|
|
$
|
155
|
|
|
Other Noncurrent Liabilities
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
Deferred income liability
(a)
|
$
|
630
|
|
$
|
660
|
|
|
Deferred compensation
|
473
|
|
454
|
|
||
|
Workers' compensation and general liability
(b)
|
306
|
|
353
|
|
||
|
Income tax
|
125
|
|
122
|
|
||
|
Pension benefits
|
46
|
|
54
|
|
||
|
Other
|
280
|
|
254
|
|
||
|
Total
|
$
|
1,860
|
|
$
|
1,897
|
|
|
(a)
|
Represents deferred income related to the Pharmacy Transaction. See Note
6
for more information.
|
|
(b)
|
See footnote
(b)
to the Accrued and Other Current Liabilities table in Note
18
for additional detail.
|
|
Share Repurchases
(millions, except per share data)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Total number of shares purchased
|
50.9
|
|
44.7
|
|
0.8
|
|
|||
|
Average price paid per share
|
$
|
72.35
|
|
$
|
77.07
|
|
$
|
54.07
|
|
|
Total investment
|
$
|
3,686
|
|
$
|
3,441
|
|
$
|
41
|
|
|
Restricted Stock Unit Activity
|
Total Nonvested Units
|
||||
|
|
Restricted
Stock
(a)
|
|
Grant Date
Fair Value
(b)
|
|
|
|
January 30, 2016
|
4,226
|
|
$
|
69.49
|
|
|
Granted
|
639
|
|
74.05
|
|
|
|
Forfeited
|
(358
|
)
|
71.37
|
|
|
|
Vested
|
(1,168
|
)
|
64.37
|
|
|
|
January 28, 2017
|
3,339
|
|
$
|
71.62
|
|
|
(a)
|
Represents the number of shares of restricted stock units, in thousands. For performance-based restricted stock units, assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding restricted stock units and performance-based restricted stock units at
January 28, 2017
was
2,765 thousand
.
|
|
(b)
|
Weighted average per unit.
|
|
Performance Share Unit Activity
|
Total Nonvested Units
|
||||
|
|
Performance
Share Units
(a)
|
|
Grant Date
Fair Value
(b)
|
|
|
|
January 30, 2016
|
4,023
|
|
$
|
70.70
|
|
|
Granted
|
712
|
|
71.37
|
|
|
|
Forfeited
|
(754
|
)
|
73.21
|
|
|
|
Vested
|
(8
|
)
|
63.54
|
|
|
|
January 28, 2017
|
3,973
|
|
$
|
70.55
|
|
|
(a)
|
Represents the number of performance share units, in thousands. Assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding units at
January 28, 2017
was
1,799 thousand
.
|
|
(b)
|
Weighted average per unit.
|
|
Stock Option Activity
|
Stock Options
|
||||||||||||||||
|
|
Total Outstanding
|
|
Exercisable
|
||||||||||||||
|
|
Number of
Options
(a)
|
|
Exercise
Price
(b)
|
|
Intrinsic
Value
(c)
|
|
|
Number of
Options
(a)
|
|
Exercise
Price
(b)
|
|
Intrinsic
Value
(c)
|
|
||||
|
January 30, 2016
|
10,500
|
|
$
|
53.47
|
|
$
|
199
|
|
|
9,405
|
|
$
|
52.57
|
|
$
|
187
|
|
|
Granted
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
|
||||
|
Expired/forfeited
|
(133
|
)
|
60.24
|
|
|
|
|
|
|
|
|
|
|
||||
|
Exercised/issued
|
(4,157
|
)
|
52.93
|
|
|
|
|
|
|
|
|
|
|
||||
|
January 28, 2017
|
6,210
|
|
$
|
53.68
|
|
$
|
63
|
|
|
6,180
|
|
$
|
53.60
|
|
$
|
63
|
|
|
(a)
|
In thousands.
|
|
(b)
|
Weighted average per share.
|
|
(c)
|
Represents stock price appreciation subsequent to the grant date, in millions.
|
|
Stock Option Exercises
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Cash received for exercise price
|
$
|
219
|
|
$
|
303
|
|
$
|
374
|
|
|
Intrinsic value
|
103
|
|
159
|
|
143
|
|
|||
|
Income tax benefit
|
40
|
|
77
|
|
41
|
|
|||
|
Plan Expenses
|
|
|
|
||||||
|
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
401(k) plan matching contributions expense
|
$
|
197
|
|
$
|
224
|
|
$
|
220
|
|
|
|
|
|
|
||||||
|
Nonqualified deferred compensation plans
|
|
|
|
||||||
|
Benefits expense
(a)
|
58
|
|
5
|
|
52
|
|
|||
|
Related investment (income) expense
(b)
|
(38
|
)
|
15
|
|
(45
|
)
|
|||
|
Nonqualified plan net expense
|
$
|
20
|
|
$
|
20
|
|
$
|
7
|
|
|
(a)
|
Includes market-performance credits on accumulated participant account balances and annual crediting for additional benefits earned during the year.
|
|
(b)
|
Includes investment returns and life-insurance proceeds received from company-owned life insurance policies and other investments used to economically hedge the cost of these plans.
|
|
Funded Status
|
Qualified Plans
|
|
Nonqualified Plans
|
||||||||||
|
(millions)
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||
|
Projected benefit obligations
|
$
|
3,760
|
|
$
|
3,558
|
|
|
$
|
32
|
|
$
|
39
|
|
|
Fair value of plan assets
|
3,785
|
|
3,607
|
|
|
—
|
|
—
|
|
||||
|
Funded
/
(underfunded) status
|
$
|
25
|
|
$
|
49
|
|
|
$
|
(32
|
)
|
$
|
(39
|
)
|
|
Estimated Future Benefit Payments
(millions)
|
Pension
Benefits
|
|
|
|
2017
|
$
|
163
|
|
|
2018
|
171
|
|
|
|
2019
|
179
|
|
|
|
2020
|
188
|
|
|
|
2021
|
197
|
|
|
|
2022-2026
|
1,112
|
|
|
|
Net Pension Benefits Expense
|
|
|
|
||||||
|
(millions)
|
2016
|
|
2015
|
|
2014
|
|
|||
|
Service cost benefits earned during the period
|
$
|
87
|
|
$
|
109
|
|
$
|
112
|
|
|
Interest cost on projected benefit obligation
|
134
|
|
154
|
|
149
|
|
|||
|
Expected return on assets
|
(256
|
)
|
(260
|
)
|
(233
|
)
|
|||
|
Amortization of losses
|
46
|
|
82
|
|
65
|
|
|||
|
Amortization of prior service cost
(a)
|
(11
|
)
|
(11
|
)
|
(11
|
)
|
|||
|
Settlement and special termination charges
|
2
|
|
4
|
|
—
|
|
|||
|
Total
|
$
|
2
|
|
$
|
78
|
|
$
|
82
|
|
|
(a)
|
Determined using the straight-line method over the average remaining service period of team members expected to receive benefits under the plan.
|
|
Benefit Obligation Weighted Average Assumptions
|
|
|||
|
|
2016
|
|
2015
|
|
|
Discount rate
|
4.40
|
%
|
4.70
|
%
|
|
Average assumed rate of compensation increase
|
3.00
|
|
3.00
|
|
|
Net Periodic Benefit Expense Weighted Average Assumptions
|
|
|||||
|
|
2016
|
|
2015
|
|
2014
|
|
|
Discount rate
|
4.70
|
%
|
3.87
|
%
|
4.77
|
%
|
|
Expected long-term rate of return on plan assets
|
6.80
|
|
7.50
|
|
7.50
|
|
|
Average assumed rate of compensation increase
|
3.00
|
|
3.00
|
|
3.00
|
|
|
Change in Projected Benefit Obligation
|
Qualified Plans
|
|
Nonqualified Plans
|
||||||||||
|
(millions)
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||
|
Benefit obligation at beginning of period
|
$
|
3,558
|
|
$
|
3,844
|
|
|
$
|
39
|
|
$
|
43
|
|
|
Service cost
|
86
|
|
108
|
|
|
1
|
|
1
|
|
||||
|
Interest cost
|
133
|
|
152
|
|
|
1
|
|
2
|
|
||||
|
Actuarial loss
/
(gain)
|
156
|
|
(400
|
)
|
|
(2
|
)
|
(4
|
)
|
||||
|
Participant contributions
|
7
|
|
6
|
|
|
—
|
|
—
|
|
||||
|
Benefits paid
|
(180
|
)
|
(155
|
)
|
|
(7
|
)
|
(3
|
)
|
||||
|
Plan amendments
|
—
|
|
3
|
|
|
—
|
|
—
|
|
||||
|
Benefit obligation at end of period
(a)
|
$
|
3,760
|
|
$
|
3,558
|
|
|
$
|
32
|
|
$
|
39
|
|
|
(a)
|
Accumulated benefit obligation—the present value of benefits earned to date assuming no future salary growth—is materially consistent with the projected benefit obligation in each period presented.
|
|
Change in Plan Assets
|
Qualified Plans
|
|
Nonqualified Plans
|
||||||||||
|
(millions)
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||
|
Fair value of plan assets at beginning of period
|
$
|
3,607
|
|
$
|
3,784
|
|
|
$
|
—
|
|
$
|
—
|
|
|
Actual return on plan assets
|
349
|
|
(231
|
)
|
|
—
|
|
—
|
|
||||
|
Employer contributions
|
2
|
|
203
|
|
|
7
|
|
3
|
|
||||
|
Participant contributions
|
7
|
|
6
|
|
|
—
|
|
—
|
|
||||
|
Benefits paid
|
(180
|
)
|
(155
|
)
|
|
(7
|
)
|
(3
|
)
|
||||
|
Fair value of plan assets at end of period
|
$
|
3,785
|
|
$
|
3,607
|
|
|
$
|
—
|
|
$
|
—
|
|
|
Asset Category
|
Current Targeted
|
|
Actual Allocation
|
|||
|
|
Allocation
|
|
2016
|
|
2015
|
|
|
Domestic equity securities
(a)
|
14
|
%
|
14
|
%
|
16
|
%
|
|
International equity securities
|
9
|
|
9
|
|
10
|
|
|
Debt securities
|
45
|
|
43
|
|
44
|
|
|
Balanced funds
|
23
|
|
25
|
|
21
|
|
|
Other
(b)
|
9
|
|
9
|
|
9
|
|
|
Total
|
100
|
%
|
100
|
%
|
100
|
%
|
|
(a)
|
Equity securities include our common stock in amounts substantially less than
1 percent
of total plan assets as of
January 28, 2017
and
January 30, 2016
.
|
|
(b)
|
Other assets include private equity, mezzanine and high-yield debt, natural resources and timberland funds, multi-strategy hedge funds, derivative instruments, and real estate. The real estate allocation represents
4 percent
of total assets.
|
|
Fair Value Measurements
|
|
Fair Value at
|
||||||
|
(millions)
|
Pricing Category
|
January 31, 2017
|
|
|
January 30, 2016
|
|
||
|
Cash and cash equivalents
|
Level 1
|
$
|
5
|
|
|
$
|
43
|
|
|
Government securities
(a)
|
Level 2
|
477
|
|
|
470
|
|
||
|
Fixed income
(b)
|
Level 2
|
1,080
|
|
|
979
|
|
||
|
Other
(c)
|
Level 2
|
4
|
|
|
8
|
|
||
|
|
|
1,566
|
|
|
1,500
|
|
||
|
Investments valued using NAV per share
(d)
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
168
|
|
|
455
|
|
||
|
Common collective trusts
|
|
768
|
|
|
544
|
|
||
|
Fixed Income
|
|
51
|
|
|
49
|
|
||
|
Balanced funds
|
|
942
|
|
|
756
|
|
||
|
Private equity funds
|
|
126
|
|
|
141
|
|
||
|
Other
|
|
164
|
|
|
162
|
|
||
|
Total plan assets
|
|
$
|
3,785
|
|
|
$
|
3,607
|
|
|
(a)
|
Investments in government securities and long-term government bonds.
|
|
(b)
|
Investments in corporate and municipal bonds.
|
|
(c)
|
Investments in derivative investments.
|
|
(d)
|
In accordance with Subtopic 820-10, certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statement of financial position.
|
|
Position
|
|
Valuation Technique
|
|
Cash and cash equivalents
|
|
Carrying value approximates fair value.
|
|
Government securities
and fixed income
|
|
Valued using matrix pricing models and quoted prices of securities with similar characteristics.
|
|
Derivatives
|
|
Swap derivatives - Valued initially using models calibrated to initial trade price. Subsequent valuations are based on observable inputs to the valuation model (e.g., interest rates and credit spreads). Model inputs are changed only when corroborated by market data. A credit risk adjustment is made on each swap using observable market credit spreads.
Option derivatives - Valued at transaction price initially. Subsequent valuations are based on observable inputs to the valuation model (e.g., underlying investments).
|
|
Amounts in Accumulated Other Comprehensive Income
|
|
|||||
|
(millions)
|
2016
|
|
2015
|
|
||
|
Net actuarial loss
|
$
|
1,035
|
|
$
|
1,022
|
|
|
Prior service credits
|
(46
|
)
|
(57
|
)
|
||
|
Amounts in accumulated other comprehensive income
(a)(b)
|
$
|
989
|
|
$
|
965
|
|
|
(a)
|
$601 million
and
$583 million
, net of tax, at the end of 2016 and 2015, respectively.
|
|
(b)
|
We expect 2017 net pension expense to include amortization expense of
$49 million
(
$30 million
, net of tax) to net actuarial loss and prior service credit balances included in accumulated other comprehensive income.
|
|
(millions)
|
Cash Flow
Hedges
|
|
|
Currency
Translation
Adjustment
|
|
|
Pension and
Other
Benefit
|
|
|
Total
|
|
||||
|
January 30, 2016
|
$
|
(19
|
)
|
|
$
|
(22
|
)
|
|
$
|
(588
|
)
|
|
$
|
(629
|
)
|
|
Other comprehensive income
/
(loss) before reclassifications
|
—
|
|
|
1
|
|
|
(32
|
)
|
|
(31
|
)
|
||||
|
Amounts reclassified from AOCI
|
3
|
|
(a)
|
—
|
|
|
19
|
|
(b)
|
22
|
|
||||
|
January 28, 2017
|
$
|
(16
|
)
|
|
$
|
(21
|
)
|
|
$
|
(601
|
)
|
|
$
|
(638
|
)
|
|
(a)
|
Represents gains and losses on cash flow hedges, net of
$2 million
of taxes, which are recorded in net interest expense on the Consolidated Statements of Operations.
|
|
(b)
|
Represents amortization of pension and other benefit liabilities, net of
$12 million
of taxes, which is recorded in SG&A expenses on the Consolidated Statements of Operations. See Note
28
for additional information.
|
|
Business Segment Results
|
2016
|
|
|
2015
|
|
|
2014
|
|
|||
|
(millions)
|
|
|
|||||||||
|
Sales
|
$
|
69,495
|
|
|
$
|
73,785
|
|
|
$
|
72,618
|
|
|
Cost of sales
|
48,872
|
|
|
51,997
|
|
|
51,278
|
|
|||
|
Gross margin
|
20,623
|
|
|
21,788
|
|
|
21,340
|
|
|||
|
Selling, general, and administrative expenses
(e)
|
13,360
|
|
|
14,448
|
|
|
14,503
|
|
|||
|
Depreciation and amortization
|
2,298
|
|
|
2,213
|
|
|
2,129
|
|
|||
|
Segment earnings before interest expense and income taxes
|
4,965
|
|
|
5,127
|
|
|
4,708
|
|
|||
|
Gain on sale
(a)
|
—
|
|
|
620
|
|
|
—
|
|
|||
|
Restructuring costs
(b)(e)
|
—
|
|
|
(138
|
)
|
|
—
|
|
|||
|
Data breach-related costs, net of insurance
(c)(e)
|
—
|
|
|
(39
|
)
|
|
(145
|
)
|
|||
|
Other
(d)(e)
|
4
|
|
|
(39
|
)
|
|
(29
|
)
|
|||
|
Earnings from continuing operations before interest expense and income taxes
|
4,969
|
|
|
5,530
|
|
|
4,535
|
|
|||
|
Net interest expense
|
1,004
|
|
|
607
|
|
|
882
|
|
|||
|
Earnings from continuing operations before income taxes
|
$
|
3,965
|
|
|
$
|
4,923
|
|
|
$
|
3,653
|
|
|
(a)
|
For 2015, represents the gain on the Pharmacy Transaction.
|
|
(b)
|
Refer to Note
8
for more information on restructuring costs.
|
|
(c)
|
Refer to Note
19
for more information on data breach-related costs.
|
|
(d)
|
For 2016, represents items related to the Pharmacy Transaction. For 2015, represents impairments related to our decision to wind down certain noncore operations. For 2014, includes impairments of
$16 million
related to undeveloped land in the U.S. and
$13 million
of expense related to converting co-branded card program to MasterCard.
|
|
(e)
|
The sum of segment SG&A expenses, restructuring costs, data breach-related costs, and other charges equal consolidated SG&A expenses.
|
|
Total Assets by Segment
(millions)
|
January 28,
2017 |
|
January 30,
2016 |
|
||
|
U.S.
|
$
|
37,350
|
|
$
|
39,845
|
|
|
Assets of discontinued operations
|
81
|
|
397
|
|
||
|
Unallocated assets
(a)
|
—
|
|
20
|
|
||
|
Total assets
|
$
|
37,431
|
|
$
|
40,262
|
|
|
(a)
|
Represents the insurance receivable related to the 2013 data breach.
|
|
Quarterly Results
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
|
Total Year
|
|||||||||||||||||||||||||
|
(millions, except per share data)
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||||||||
|
Sales
|
$
|
16,196
|
|
$
|
17,119
|
|
|
$
|
16,169
|
|
$
|
17,427
|
|
|
$
|
16,441
|
|
$
|
17,613
|
|
|
$
|
20,690
|
|
$
|
21,626
|
|
|
$
|
69,495
|
|
$
|
73,785
|
|
|
Cost of sales
|
11,185
|
|
11,911
|
|
|
11,102
|
|
12,051
|
|
|
11,471
|
|
12,440
|
|
|
15,116
|
|
15,594
|
|
|
48,872
|
|
51,997
|
|
||||||||||
|
Gross margin
|
5,011
|
|
5,208
|
|
|
5,067
|
|
5,376
|
|
|
4,970
|
|
5,173
|
|
|
5,574
|
|
6,032
|
|
|
20,623
|
|
21,788
|
|
||||||||||
|
Selling, general, and administrative expenses
|
3,153
|
|
3,514
|
|
|
3,249
|
|
3,495
|
|
|
3,339
|
|
3,736
|
|
|
3,614
|
|
3,921
|
|
|
13,356
|
|
14,665
|
|
||||||||||
|
Depreciation and amortization
|
546
|
|
540
|
|
|
570
|
|
551
|
|
|
570
|
|
561
|
|
|
612
|
|
562
|
|
|
2,298
|
|
2,213
|
|
||||||||||
|
Gain on sale
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
(620
|
)
|
|
—
|
|
(620
|
)
|
||||||||||
|
Earnings before interest expense and income taxes
|
1,312
|
|
1,154
|
|
|
1,248
|
|
1,330
|
|
|
1,061
|
|
876
|
|
|
1,348
|
|
2,169
|
|
|
4,969
|
|
5,530
|
|
||||||||||
|
Net interest expense
|
415
|
|
155
|
|
|
307
|
|
148
|
|
|
142
|
|
151
|
|
|
140
|
|
152
|
|
|
1,004
|
|
607
|
|
||||||||||
|
Earnings from continuing operations before income taxes
|
897
|
|
999
|
|
|
941
|
|
1,182
|
|
|
919
|
|
725
|
|
|
1,208
|
|
2,017
|
|
|
3,965
|
|
4,923
|
|
||||||||||
|
Provision for income taxes
|
283
|
|
348
|
|
|
316
|
|
409
|
|
|
311
|
|
249
|
|
|
387
|
|
596
|
|
|
1,296
|
|
1,602
|
|
||||||||||
|
Net earnings from continuing operations
|
614
|
|
651
|
|
|
625
|
|
773
|
|
|
608
|
|
476
|
|
|
821
|
|
1,421
|
|
|
2,669
|
|
3,321
|
|
||||||||||
|
Discontinued operations, net of tax
|
18
|
|
(16
|
)
|
|
55
|
|
(20
|
)
|
|
—
|
|
73
|
|
|
(4
|
)
|
5
|
|
|
68
|
|
42
|
|
||||||||||
|
Net earnings
|
$
|
632
|
|
$
|
635
|
|
|
$
|
680
|
|
$
|
753
|
|
|
$
|
608
|
|
$
|
549
|
|
|
$
|
817
|
|
$
|
1,426
|
|
|
$
|
2,737
|
|
$
|
3,363
|
|
|
Basic earnings/(loss) per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Continuing operations
|
$
|
1.03
|
|
$
|
1.02
|
|
|
$
|
1.07
|
|
$
|
1.21
|
|
|
$
|
1.07
|
|
$
|
0.76
|
|
|
$
|
1.47
|
|
$
|
2.33
|
|
|
$
|
4.62
|
|
$
|
5.29
|
|
|
Discontinued operations
|
0.03
|
|
(0.03
|
)
|
|
0.09
|
|
(0.03
|
)
|
|
—
|
|
0.12
|
|
|
(0.01
|
)
|
0.01
|
|
|
0.12
|
|
0.07
|
|
||||||||||
|
Net earnings per share
|
$
|
1.06
|
|
$
|
0.99
|
|
|
$
|
1.17
|
|
$
|
1.18
|
|
|
$
|
1.07
|
|
$
|
0.88
|
|
|
$
|
1.46
|
|
$
|
2.33
|
|
|
$
|
4.74
|
|
$
|
5.35
|
|
|
Diluted earnings/(loss) per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Continuing operations
|
$
|
1.02
|
|
$
|
1.01
|
|
|
$
|
1.07
|
|
$
|
1.21
|
|
|
$
|
1.06
|
|
$
|
0.76
|
|
|
$
|
1.46
|
|
$
|
2.31
|
|
|
$
|
4.58
|
|
$
|
5.25
|
|
|
Discontinued operations
|
0.03
|
|
(0.03
|
)
|
|
0.09
|
|
(0.03
|
)
|
|
—
|
|
0.11
|
|
|
(0.01
|
)
|
0.01
|
|
|
0.12
|
|
0.07
|
|
||||||||||
|
Net earnings per share
|
$
|
1.05
|
|
$
|
0.98
|
|
|
$
|
1.16
|
|
$
|
1.18
|
|
|
$
|
1.06
|
|
$
|
0.87
|
|
|
$
|
1.45
|
|
$
|
2.32
|
|
|
$
|
4.70
|
|
$
|
5.31
|
|
|
Dividends declared per share
|
$
|
0.56
|
|
$
|
0.52
|
|
|
$
|
0.60
|
|
$
|
0.56
|
|
|
$
|
0.60
|
|
$
|
0.56
|
|
|
$
|
0.60
|
|
$
|
0.56
|
|
|
$
|
2.36
|
|
$
|
2.20
|
|
|
Closing common stock price:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
High
|
83.98
|
|
83.57
|
|
|
80.12
|
|
85.01
|
|
|
75.81
|
|
80.87
|
|
|
78.61
|
|
78.23
|
|
|
83.98
|
|
85.01
|
|
||||||||||
|
Low
|
68.05
|
|
74.25
|
|
|
66.74
|
|
77.26
|
|
|
67.22
|
|
72.94
|
|
|
63.70
|
|
67.59
|
|
|
63.70
|
|
67.59
|
|
||||||||||
|
U.S. Sales by Product Category
(a)
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
|
Total Year
|
|||||||||||||||
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
|
Household essentials
|
23
|
%
|
28
|
%
|
|
23
|
%
|
28
|
%
|
|
23
|
%
|
28
|
%
|
|
19
|
%
|
21
|
%
|
|
22
|
%
|
26
|
%
|
|
Food, beverage, and pet supplies
|
24
|
|
22
|
|
|
22
|
|
20
|
|
|
23
|
|
22
|
|
|
20
|
|
19
|
|
|
22
|
|
21
|
|
|
Apparel and accessories
|
21
|
|
20
|
|
|
22
|
|
21
|
|
|
21
|
|
19
|
|
|
18
|
|
18
|
|
|
20
|
|
19
|
|
|
Home furnishings and décor
|
17
|
|
16
|
|
|
19
|
|
17
|
|
|
19
|
|
18
|
|
|
19
|
|
18
|
|
|
19
|
|
17
|
|
|
Hardlines
|
15
|
|
14
|
|
|
14
|
|
14
|
|
|
14
|
|
13
|
|
|
24
|
|
24
|
|
|
17
|
|
17
|
|
|
Total
|
100
|
%
|
100
|
%
|
|
100
|
%
|
100
|
%
|
|
100
|
%
|
100
|
%
|
|
100
|
%
|
100
|
%
|
|
100
|
%
|
100
|
%
|
|
Supplemental information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Pharmacy
(b)
|
—
|
%
|
6
|
%
|
|
—
|
%
|
6
|
%
|
|
—
|
%
|
6
|
%
|
|
—
|
%
|
3
|
%
|
|
—
|
%
|
5
|
%
|
|
(a)
|
As a percentage of sales.
|
|
(b)
|
Included in household essentials.
|
|
•
|
|
|
•
|
Stock Ownership Information--Section 16(a) Beneficial Ownership Reporting Compliance
|
|
•
|
General Information About Corporate Governance and the Board of Directors
|
|
◦
|
Business Ethics and Conduct
|
|
◦
|
Committees
|
|
•
|
Questions and Answers About Our Annual Meeting and Voting--Question 14
|
|
•
|
Compensation Discussion and Analysis
|
|
•
|
Compensation Tables
|
|
•
|
Human Resources & Compensation Committee Report
|
|
•
|
Stock Ownership Information--
|
|
◦
|
Beneficial Ownership of Directors and Officers
|
|
◦
|
Beneficial Ownership of Target’s Largest Shareholders
|
|
•
|
Compensation Tables--Equity Compensation Plan Information
|
|
•
|
General Information About Corporate Governance and the Board of Directors--
|
|
◦
|
Policy on Transactions with Related Persons
|
|
◦
|
Director Independence
|
|
◦
|
Committees
|
|
•
|
Item Two-- Ratification of Appointment of Ernst & Young LLP As Independent Registered Public Accounting Firm-Audit and Non-Audit Fees
|
|
a)
|
Financial Statements
|
|
•
|
Consolidated Statements of Operations for the Years Ended
January 28, 2017
,
January 30, 2016
, and
January 31, 2015
|
|
•
|
Consolidated Statements of Comprehensive Income for the Years Ended
January 28, 2017
,
January 30, 2016
, and
January 31, 2015
|
|
•
|
Consolidated Statements of Financial Position at
January 28, 2017
and
January 30, 2016
|
|
•
|
Consolidated Statements of Cash Flows for the Years Ended
January 28, 2017
,
January 30, 2016
, and
January 31, 2015
|
|
•
|
Consolidated Statements of Shareholders' Investment for the Years Ended
January 28, 2017
,
January 30, 2016
, and
January 31, 2015
|
|
•
|
Notes to Consolidated Financial Statements
|
|
•
|
Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements
|
|
Financial Statement Schedules
|
|
|
|
None.
|
|
|
|
Other schedules have not been included either because they are not applicable or because the information is included elsewhere in this Report.
|
|
b)
|
Exhibits
|
|
(2)A
|
†
|
Asset Purchase Agreement dated June 12, 2015 between Target Corporation and CVS Pharmacy, Inc. (
1
)
|
|
(3)A
|
|
Amended and Restated Articles of Incorporation (as amended through June 9, 2010)
(2)
|
|
B
|
|
Bylaws (as amended through November 11, 2015)
(3)
|
|
(4)A
|
|
Indenture, dated as of August 4, 2000 between Target Corporation and Bank One Trust Company, N.A.
(4)
|
|
B
|
|
First Supplemental Indenture dated as of May 1, 2007 to Indenture dated as of August 4, 2000 between Target Corporation and The Bank of New York Trust Company, N.A. (as successor in interest to Bank One Trust Company N.A.)
(5)
|
|
C
|
|
Target agrees to furnish to the Commission on request copies of other instruments with respect to long-term debt.
|
|
(10)A
|
*
|
Target Corporation Officer Short-Term Incentive Plan
(6)
|
|
B
|
*
|
Target Corporation Long-Term Incentive Plan (as amended and restated effective June 8, 2011)
(7)
|
|
C
|
*
|
Amended and Restated Target Corporation 2011 Long-Term Incentive Plan
(8)
|
|
D
|
*
|
Target Corporation SPP I (2016 Plan Statement) (as amended and restated effective April 3, 2016)
(9)
|
|
E
|
*
|
Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016)
(10)
|
|
F
|
*
|
Target Corporation SPP III (2014 Plan Statement) (as amended and restated effective January 1, 2014)
(11)
|
|
G
|
*
|
Amendment to Target Corporation SPP III (2014 Plan Statement) (effective April 3, 2016)
(12)
|
|
H
|
*
|
Target Corporation Officer Deferred Compensation Plan (as amended and restated effective June 8, 2011)
(13)
|
|
I
|
*
|
Target Corporation Officer EDCP (2017 Plan Statement) (as amended and restated effective May 1, 2017)
|
|
J
|
*
|
Target Corporation Deferred Compensation Plan Directors
(14)
|
|
K
|
*
|
Target Corporation DDCP (2013 Plan Statement) (as amended and restated effective December 1, 2013)
(15)
|
|
L
|
*
|
Target Corporation Officer Income Continuance Policy Statement (as amended and restated effective April 3, 2016)
(16)
|
|
M
|
*
|
Target Corporation Executive Excess Long Term Disability Plan (as restated effective January 1, 2010
(17)
|
|
N
|
*
|
Director Retirement Program
(18)
|
|
O
|
*
|
Target Corporation Deferred Compensation Trust Agreement (as amended and restated effective January 1, 2009)
(19)
|
|
P
|
*
|
Amendment to Target Corporation Deferred Compensation Trust Agreement (as amended and restated effective January 1, 2009)
(20)
|
|
Q
|
*
|
Form of Amended and Restated Executive Non-Qualified Stock Option Agreement
(21)
|
|
R
|
*
|
Form of Executive Restricted Stock Unit Agreement - Cliff Vesting
(22)
|
|
S
|
*
|
Form of Executive Restricted Stock Unit Agreement - Ratable Vesting
|
|
T
|
*
|
Form of Executive Performance-Based Restricted Stock Unit Agreement
(23)
|
|
U
|
*
|
Form of Executive Performance Share Unit Agreement
|
|
V
|
*
|
Form of Non-Employee Director Non-Qualified Stock Option Agreement
(24)
|
|
W
|
*
|
Form of Non-Employee Director Restricted Stock Unit Agreement
(25)
|
|
X
|
*
|
Form of Cash Retention Award
(26)
|
|
Y
|
|
Five-Year Credit Agreement dated as of October 5, 2016 among Target Corporation, Bank of America, N.A. as Administrative Agent and the Banks listed therein
(27)
|
|
Z
|
‡
|
Credit Card Program Agreement dated October 22, 2012 among Target Corporation, Target Enterprise, Inc. and TD Bank USA, N.A.
(28)
|
|
AA
|
‡
|
First Amendment dated February 24, 2015 to Credit Card Program Agreement among Target Corporation, Target Enterprise, Inc. and TD Bank USA, N.A.
(29)
|
|
BB
|
‡
|
Pharmacy Operating Agreement dated December 16, 2015 between Target Corporation and CVS Pharmacy, Inc.
(30)
|
|
CC
|
‡
|
First Amendment dated November 30, 2016 to Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc.
|
|
DD
|
*
|
Restricted Stock Unit Agreement with John J. Mulligan, effective as of May 22, 2014
(31)
|
|
EE
|
*
|
Employment Offer Letter to Brian C. Cornell, dated July 26, 2014
(32)
|
|
FF
|
*
|
Make-Whole Performance-Based Restricted Stock Unit Agreement with Brian C. Cornell, effective as of August 21, 2014
(33)
|
|
GG
|
*
|
Aircraft Time Sharing Agreement as of March 13, 2015 among Target Corporation and Brian C. Cornell
(34)
|
|
HH
|
*
|
Advisory Role Letter to Timothy R. Baer dated July 11, 2016
(35)
|
|
II
|
*
|
Target Corporation Officer EDCP (2017 Plan Statement) (as amended and restated effective January 1, 2017)
(36)
|
|
(12)
|
|
Statements of Computations of Ratios of Earnings to Fixed Charges
|
|
(21)
|
|
List of Subsidiaries
|
|
(23)
|
|
Consent of Independent Registered Public Accounting Firm
|
|
(24)
|
|
Powers of Attorney
|
|
(31)A
|
|
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
(31)B
|
|
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
(32)A
|
|
Certification of the Chief Executive Officer Pursuant to Section 18 U.S.C. Section 1350 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
(32)B
|
|
Certification of the Chief Financial Officer Pursuant to Section 18 U.S.C. Section 1350 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
†
|
Excludes the Seller Disclosure Schedule, Exhibits B through G and Schedules I and II referred to in the agreement which Target Corporation agrees to furnish supplementally to the Securities and Exchange Commission upon request. Exhibit A is separately filed as Exhibit (10)BB.
|
|
‡
|
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission.
|
|
*
|
Management contract or compensation plan or arrangement required to be filed as an exhibit to this Form 10-K.
|
|
(1)
|
Incorporated by reference to Exhibit (2)H to Target's Form 10-Q Report for the quarter ended August 1, 2015.
|
|
(2)
|
Incorporated by reference to Exhibit (3)A to Target's Form 8-K Report filed June 10, 2010.
|
|
(3)
|
Incorporated by reference to Exhibit (3)A to Target's Form 8-K Report filed November 12, 2015.
|
|
(4)
|
Incorporated by reference to Exhibit 4.1 to Target's Form 8-K Report filed August 10, 2000.
|
|
(5)
|
Incorporated by reference to Exhibit 4.1 to the Registrant's Form 8-K Report filed May 1, 2007.
|
|
(6)
|
Incorporated by reference to Appendix A to the Registrant's Proxy Statement filed April 30, 2012.
|
|
(7)
|
Incorporated by reference to Exhibit (10)B to Target's Form 10-Q Report for the quarter ended July 30, 2011.
|
|
(8)
|
Incorporated by reference to Exhibit (10)JJ to Target's Form 8-K Report filed June 12, 2015.
|
|
(9)
|
Incorporated by reference to Exhibit (10)C to Target's Form 10-Q Report for the quarter ended April 30, 2016.
|
|
(10)
|
Incorporated by reference to Exhibit (10)D to Target's Form 10-Q Report for the quarter ended April 30, 2016.
|
|
(11)
|
Incorporated by reference to Exhibit (10)E to Target's Form 10-K Report for the year ended February 1, 2014.
|
|
(12)
|
Incorporated by reference to Exhibit (10)NN to Target's Form 10-Q Report for the quarter ended April 30, 2016.
|
|
(13)
|
Incorporated by reference to Exhibit (10)F to Target's Form 10-Q Report for the quarter ended July 30, 2011.
|
|
(14)
|
Incorporated by reference to Exhibit (10)I to Target's Form 10-K Report for the year ended February 3, 2007.
|
|
(15)
|
Incorporated by reference to Exhibit (10)I to Target's Form 10-K Report for the year ended February 1, 2014.
|
|
(16)
|
Incorporated by reference to Exhibit (10)J to Target's Form 10-Q Report for the quarter ended April 30, 2016.
|
|
(17)
|
Incorporated by reference to Exhibit (10)A to Target's Form 10-Q Report for the quarter ended October 30, 2010.
|
|
(18)
|
Incorporated by reference to Exhibit (10)O to Target's Form 10-K Report for the year ended January 29, 2005.
|
|
(19)
|
Incorporated by reference to Exhibit (10)O to Target's Form 10-K Report for the year ended January 31, 2009.
|
|
(20)
|
Incorporated by reference to Exhibit (10)AA to Target's Form 10-Q Report for the quarter ended July 30, 2011.
|
|
(21)
|
Incorporated by reference to Exhibit (10)V to Target's Form 10-K Report for the year ended January 31, 2015.
|
|
(22)
|
Incorporated by reference to Exhibit (10)W to Target's Form 10-K Report for the year ended January 30, 2016.
|
|
(23)
|
Incorporated by reference to Exhibit (10)X to Target's Form 10-K Report for the year ended January 30, 2016
.
|
|
(24)
|
Incorporated by reference to Exhibit (10)EE to Target's Form 8-K Report filed January 11, 2012.
|
|
(25)
|
Incorporated by reference to Exhibit (10)AA to Target's Form 10-K Report for the year ended January 30, 2016.
|
|
(26)
|
Incorporated by reference to Exhibit (10)W to Target’s Form 10-K Report for year ended February 2, 2013.
|
|
(27)
|
Incorporated by reference to Exhibit (10)O to Target's Form 10-Q Report for the quarter ended October 29, 2016.
|
|
(28)
|
Incorporated by reference to Exhibit (10)X to Target's Form 10-Q/A Report for the quarter ended May 4, 2013.
|
|
(29)
|
Incorporated by reference to Exhibit (10)II to Target's Form 10-Q Report for the quarter ended May 2, 2015.
|
|
(30)
|
Incorporated by reference to Exhibit (10)KK to Target's Form 10-K Report for the year ended January 30, 2016.
|
|
(31)
|
Incorporated by reference to Exhibit (10)BB to Target's Form 10-Q Report for the quarter ended August 2, 2014.
|
|
(32)
|
Incorporated by reference to Exhibit (10)CC to Target's Form 10-Q Report for the quarter ended August 2, 2014.
|
|
(33)
|
Incorporated by reference to Exhibit (10)EE to Target's Form 10-Q Report for the quarter ended August 2, 2014.
|
|
(34)
|
Incorporated by reference to Exhibit (10)HH to Target's Form 10-K Report for the year ended January 31, 2015.
|
|
(35)
|
Incorporated by reference to Exhibit (10)OO to Target's Form 10-Q Report for the quarter ended July 30, 2016.
|
|
(36)
|
Incorporated by reference to Exhibit (10)G to Target's 10-Q Report for the quarter ended October 29, 2016.
|
|
|
|
|
|
|
TARGET CORPORATION
|
|
|
|
By:
|
|
|
Dated: March 8, 2017
|
|
Cathy R. Smith
Executive Vice President and Chief Financial Officer
|
|
|
|
|
Dated: March 8, 2017
|
Brian C. Cornell
Chairman of the Board and Chief Executive Officer
|
|
|
|
|
Dated: March 8, 2017
|
Cathy R. Smith
Executive Vice President and Chief Financial Officer |
|
|
|
|
Dated: March 8, 2017
|
Robert M. Harrison
Senior Vice President, Chief Accounting Officer
and Controller
|
|
ROXANNE S. AUSTIN
DOUGLAS M. BAKER, JR.
CALVIN DARDEN
HENRIQUE DE CASTRO
ROBERT L. EDWARDS
MELANIE L. HEALEY
|
|
DONALD R. KNAUSS
MONICA C. LOZANO
MARY E. MINNICK
ANNE M. MULCAHY
DERICA W. RICE
KENNETH L. SALAZAR
|
|
Constituting a majority of the Board of Directors
|
|
|
By:
|
|
|
Dated: March 8, 2017
|
|
Cathy R. Smith
Attorney-in-fact |
|
Exhibit
|
Description
|
Manner of Filing
|
|
(2)A
|
Asset Purchase Agreement dated June 12, 2015 between Target Corporation and CVS Pharmacy, Inc.
|
Incorporated by Reference
|
|
(3)A
|
Amended and Restated Articles of Incorporation (as amended June 9, 2010)
|
Incorporated by Reference
|
|
(3)B
|
Bylaws (as amended through November 11, 2015)
|
Incorporated by Reference
|
|
(4)A
|
Indenture, dated as of August 4, 2000 between Target Corporation and Bank One Trust Company, N.A.
|
Incorporated by Reference
|
|
(4)B
|
First Supplemental Indenture dated as of May 1, 2007 to Indenture dated as of August 4, 2000 between Target Corporation and The Bank of New York Trust Company, N.A. (as successor in interest to Bank One Trust Company N.A.)
|
Incorporated by Reference
|
|
(4)C
|
Target agrees to furnish to the Commission on request copies of other instruments with respect to long-term debt.
|
Filed Electronically
|
|
(10)A
|
Target Corporation Officer Short-Term Incentive Plan
|
Incorporated by Reference
|
|
(10)B
|
Target Corporation Long-Term Incentive Plan (as amended and restated effective June 8, 2011)
|
Incorporated by Reference
|
|
(10)C
|
Amended and Restated Target Corporation 2011 Long-Term Incentive Plan
|
Incorporated by Reference
|
|
(10)D
|
Target Corporation SPP I (2016 Plan Statement) (as amended and restated effective April 3, 2016)
|
Incorporated by Reference
|
|
(10)E
|
Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016)
|
Incorporated by Reference
|
|
(10)F
|
Target Corporation SPP III (2014 Plan Statement) (as amended and restated effective January 1, 2014)
|
Incorporated by Reference
|
|
(10)G
|
Amendment to Target Corporation SPP III (2014 Plan Statement) (effective April 3, 2016)
|
Incorporated by Reference
|
|
(10)H
|
Target Corporation Officer Deferred Compensation Plan (as amended and restated effective June 8, 2011)
|
Incorporated by Reference
|
|
(10)I
|
Target Corporation Officer EDCP (2017 Plan Statement) (as amended and restated effective May 1, 2017)
|
Filed Electronically
|
|
(10)J
|
Target Corporation Deferred Compensation Plan Directors
|
Incorporated by Reference
|
|
(10)K
|
Target Corporation DDCP (2013 Plan Statement) (as amended and restated effective December 1, 2013)
|
Incorporated by Reference
|
|
(10)L
|
Target Corporation Officer Income Continuance Policy Statement (as amended and restated effective April 3, 2016)
|
Incorporated by Reference
|
|
(10)M
|
Target Corporation Executive Excess Long Term Disability Plan (as restated effective January 1, 2010)
|
Incorporated by Reference
|
|
(10)N
|
Director Retirement Program
|
Incorporated by Reference
|
|
(10)O
|
Target Corporation Deferred Compensation Trust Agreement (as amended and restated effective January 1, 2009)
|
Incorporated by Reference
|
|
(10)P
|
Amendment to Target Corporation Deferred Compensation Trust Agreement (as amended and restated effective January 1, 2009)
|
Incorporated by Reference
|
|
(10)Q
|
Form of Amended and Restated Executive Non-Qualified Stock Option Agreement
|
Incorporated by Reference
|
|
(10)R
|
Form of Executive Restricted Stock Unit Agreement - Cliff Vesting
|
Incorporated by Reference
|
|
(10)S
|
Form of Executive Restricted Stock Unit Agreement - Ratable Vesting
|
Filed Electronically
|
|
(10)T
|
Form of Executive Performance-Based Restricted Stock Unit Agreement
|
Incorporated by Reference
|
|
(10)U
|
Form of Executive Performance Share Unit Agreement
|
Filed Electronically
|
|
(10)V
|
Form of Non-Employee Director Non-Qualified Stock Option Agreement
|
Incorporated by Reference
|
|
(10)W
|
Form of Non-Employee Director Restricted Stock Unit Agreement
|
Incorporated by Reference
|
|
(10)X
|
Form of Cash Retention Award
|
Incorporated by Reference
|
|
(10)Y
|
Five-Year Credit Agreement dated as of October 5, 2016 among Target Corporation, Bank of America, N.A. as Administrative Agent and the Banks listed therein
|
Incorporated by Reference
|
|
(10)Z
|
Credit Card Program Agreement dated October 22, 2012 among Target Corporation, Target Enterprise, Inc. and TD Bank USA, N.A.
|
Incorporated by Reference
|
|
(10)AA
|
First Amendment dated February 24, 2015 to Credit Card Program Agreement among Target Corporation, Target Enterprise, Inc. and TD Bank USA, N.A.
|
Incorporated by Reference
|
|
(10)BB
|
Pharmacy Operating Agreement dated December 16, 2015 between Target Corporation and CVS Pharmacy, Inc.
|
Incorporated by Reference
|
|
(10)CC
|
First Amendment dated November 30, 2016 to Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc.
|
Filed Electronically
|
|
(10)DD
|
Restricted Stock Unit Agreement with John J. Mulligan, effective as of May 22, 2014
|
Incorporated by Reference
|
|
(10)EE
|
Employment Offer Letter to Brian C. Cornell, dated July 26, 2014
|
Incorporated by Reference
|
|
(10)FF
|
Make-Whole Performance-Based Restricted Stock Unit Agreement with Brian C. Cornell, effective as of August 21, 2014
|
Incorporated by Reference
|
|
(10)GG
|
Aircraft Time Sharing Agreement as of March 13, 2015 among Target Corporation and Brian C. Cornell
|
Incorporated by Reference
|
|
(10)HH
|
Advisory Role Letter to Timothy R. Baer dated July 11, 2016
|
Incorporated by Reference
|
|
(10)II
|
Target Corporation Officer EDCP (2017 Plan Statement) (as amended and restated effective January 1, 2017)
|
Incorporated by Reference
|
|
(12)
|
Statements of Computations of Ratios of Earnings to Fixed Charges
|
Filed Electronically
|
|
(21)
|
List of Subsidiaries
|
Filed Electronically
|
|
(23)
|
Consent of Independent Registered Public Accounting Firm
|
Filed Electronically
|
|
(24)
|
Powers of Attorney
|
Filed Electronically
|
|
(31)A
|
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
Filed Electronically
|
|
(31)B
|
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
Filed Electronically
|
|
(32)A
|
Certification of the Chief Executive Officer Pursuant to Section 18 U.S.C. Section 1350 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed Electronically
|
|
(32)B
|
Certification of the Chief Financial Officer Pursuant to Section 18 U.S.C. Section 1350 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Filed Electronically
|
|
101.INS
|
XBRL Instance Document
|
Filed Electronically
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
Filed Electronically
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
Filed Electronically
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
Filed Electronically
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
Filed Electronically
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase
|
Filed Electronically
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Suppliers
| Supplier name | Ticker |
|---|---|
| Apple Inc. | AAPL |
| Abercrombie & Fitch Co. | ANF |
| Conagra Brands, Inc. | CAG |
| Church & Dwight Co., Inc. | CHD |
| Delta Apparel, Inc. | DLA |
| Fastenal Company | FAST |
| National Beverage Corp. | FIZZ |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|